People of The Industry

SynBioBeta is focused on connecting the synthetic biology community. Our database features leaders from around the globe, focused on a wide range of industry professionals from researchers and biohackers to startup founders and angel investors.  Browse through over 300 professionals that are playing an important role in the advancement of the industry.

Want to be added to the database? Please contact us.
Filter Options:
Title: Company:

Aaron Nesser - Research Director

AlgiKnit

Aaron Nesser is devoted to creating a sustainable future where the arts and sciences merge and living organisms are found in everyday items like clothes and furniture. Imagine feeding your shirt! He is the Research Director at …

Adam Clore - Scientific Applications Specialist

Integrated DNA Technologies

Adam Clore is a Scientific Applications Specialist at Integrated DNA Technologies. He has a background in microbiology and biochemistry and studied the molecular genetics of hyperthermophilic archaea and their viruses for his PhD in Biology. His roles …

Adam D’Augelli - Principal

True Ventures

Adam D’Augelli is a Principal at True Ventures. True works with promising entrepreneurs at the earliest stages in the technology market providing hands-on management support to guide portfolio companies through the challenges of early growth.  Prior to …

Adam Goulburn - Senior Associate

Lux Capital

Adam Goulburn is a Senior Associate with Lux Capital, based in the firm’s New York headquarters. Adam concentrates on investments within the healthcare and life science sectors. Adam focuses on broad investment opportunities in healthcare IT, services, …

Alan Villalobos - Vice President of Synthetic Biology

DNA2.0

Alan is the Vice President of Synthetic Biology at DNA2.0. He received his Computer Engineering degree from Instituto Tecnológico de Costa Rica and in 2005 joined DNA2.0 to build the company’s data management platform. Over the last …

Aleksandra Wlodek - Senior Biologist

Isomerase Therapeutics

Aleksandra Wlodek is a senior biologist at Isomerase Therapeutics. By bridging synthetic biology and biosynthetic medicinal chemistry she develops new tools to create the designer natural products. She earned her PhD at the University of Cambridge after completing undergraduate …

Alex Pudney - Synthetic Biology Team Leader

ZuvaSyntha

Alex Pudney is Synthetic Biology Team Leader at ZuvaSyntha. Prior, he was a Molecular Biologist at TMO Renewables Ltd and a Post-Doctoral Research Assistant at Imperial College London.

Alexander Williams - Bioinformatics Software Engineer

UC San Francisco

Alexander Williams received an MS in Computer Science from Stanford in 2004 and an MS in Bioinformatics from Santa Cruz in 2010, where he worked on drug target prediction in yeast. He maintains a repository of command-line scientific …

Alexandra Daisy Ginsberg -

Alexandra Daisy Ginsberg is a designer, artist and writer. Seeking new roles for design, Daisy is developing experimental design approaches to help us imagine alternative ideals around technology. Through the design of objects, workshops, and writing and …

Alexandre Zanghellini - Chief Executive Officer

Arzeda

Alexandre Zanghellini co-founded Arzeda and currently serves as its Chief Executive Officer. He leads Arzeda’s product and technology development  and is responsible for day-to-day operations. Alex is one of the key inventors of Arzeda’s synthetic biology platform …

Alexia Chandor-Proust - Research and Development Manager

BGene Genetics

Alexia Chandor-Proust is partner and head of R&D at BGene since 2013. She obtained her Master of Science in Chemistry (Chimie-ParisTech) and a Master’s degree in drug metabolism (University Paris V) in 2005. Specialized in Biochemistry since her …

Alfred Ho - Chief Operating Officer

Morph Bioinformatics

Alfred Ho is the Chief Operating Officer and Co-Founder of Morph Bioinformatics – an iGEM startup offering tailored solutions, mobile apps and a social platform for bioscientists and bioinformaticians. He just completed his degree in Biomedical Sciences …

Alice Gast - President

Imperial College London

Prior to her appointment at Imperial, Professor Gast was the 13th President of Lehigh University, Pennsylvania, USA, from August 2006 to August 2014. Other leadership roles include serving as the Vice-President for Research and Associate Provost and …

Alicia Jackson - Former Deputy Director of the Biological Technologies Office

DARPA

Dr. Alicia Jackson launched and served as the Deputy Director of the Biological Technologies Office (BTO) at the Defense Advanced Research Projects Agency (DARPA), the Pentagon’s principal engine for disruptive innovation. BTO is DARPA’s technology arm focused …

Allison Pieja -

Allison received her Ph.D. in Civil & Environmental Engineering in 2011 from Stanford University, with a focus on selection of microbes for the production of PHA from methane. She received her B.S.E. from Princeton University in 2004. …

Alon Ben-Shoshan - VP of Strategy and Development

Genome Compiler

Alon is a technology entrepreneur who specializes in bringing disruptive innovations to market. As an engineer, Alon has played both technical and business leadership roles in early stage companies ranging from the advanced materials industry to enterprise …

Amanda Cashin - Head of Illumina Accelerator

Illumina

Amanda Cashin, Ph.D. is Head of the Illumina Accelerator in San Francisco, California. Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Previously, Amanda was SVP of …

Amy Liao - CEO

GENEWIZ

Dr. Amy Liao is the President and Chief Operating Officer of GENEWIZ Inc. Amy is a co-founder of GENEWIZ and has held a critical leadership role in the company’s growth since its founding in 1999. Amy received …

Amy Tayler - Knowledge Transfer Manager

Knowledge Transfer Network

Amy is the KTN’s Knowledge Transfer Manager for synthetic biology, and coordinates the Synthetic Biology Special Interest Group (SynBio SIG). She also supports the activity of the Synthetic Biology Leadership Council (SBLC), which provides a steering structure and governance …

Andre Watson -

Andre is Founder of Ligandal, a gene editing delivery company. Ligandal has developed a breakthrough technique for delivering gene editing tools such as CRISPR and TALEN with non-viral nanocarriers, circumventing many of the issues associated with use of …

Andreas Meyer - PhD

FGen

Andreas Meyer is CEO and co-founder of FGen, a company active in the field of bio-engineering and high throughput screening. As an entrepreneur he is particularly interested in technology driven companies and open innovation. Andreas earned his PhD in biotechnology from …

Andrew Ellis - Technical Director

Biocatalysts

Andy was awarded a 1st class (hons) degree in Microbiology from the University of Leeds, UK. This was followed by a Unilever sponsored PhD in enzymology at Cardiff University. Andy joined Biocatalysts in 2002 shortly after finishing …

Andrew Herr - President

Helicase

Andrew Herr founded and manages Helicase LLC and Mind+Matter LLC. Helicase is a technology and strategy consulting firm which specializes in developing, conducting, and implementing tailored studies and programs for corporate and government clients. Helicase’s core areas …

Andrew Hessel - Autodesk Distinguished Researcher

Autodesk

Autodesk Distinguished Researcher Andrew Hessel is a catalyst in biological technologies, helping industry, academics, and authorities better understand the changes happening in life science. He is also the co-founder of the Pink Army Cooperative, the world’s first …

Andrew May - Chief Scientific Officer

Caribou Biosciences

Andy May leads the research and development team at Caribou Biosciences and has a background in both developing technologies as well as bringing innovative products from concept to commercialization. Before joining Caribou, Andy led development teams in …

Andrew Phillips - Head of Biological Computation Group

Microsoft Research

Andrew Phillips is head of the Biological Computation group at Microsoft Research Cambridge, where he is currently developing languages and methods for analyzing and programming biological systems. Andrew received a postgraduate degree in Computer Science from the …

Andrew Soare - Senior Analyst

Lux Research

As a Senior Analyst at Lux Research, Andrew Soare leads the Alternative Fuels Intelligence service and the Bio-based Materials and Chemicals Intelligence service, where he regularly analyzes technologies, strategies, and business models of emerging companies. These technology domains focus …

Andrew Spicer - Chief Research Scientist

Algenuity

Andrew Spicer is the Chief Research Scientist and Scientific Director of Algenuity. Andrew received a Ph.D. in Molecular and Cell Biology in 1993 from University College London through his doctoral research at the Imperial Cancer Research Fund …

Andy Bass - CEO

BioPop

Andy Bass is a co-founder and CEO of Biological & Popular Culture, Inc. (BioPop). He is often described as a renaissance man by those who know him best. Born on a farm in Hazel Green, Alabama his …

Andy Boyce - Innovations Manager

BrisSynBio

Andy is the Innovations Manager for BrisSynBio. He is responsible for supporting translation of BrisSynBio’s world-class reserach and leads the BrisSynBio Innovation Programme. Prior to joining BrisSynBio, Andy managed KTN’s Synthetic Biology Special Interest Group, a programme …

Andy Smith - Chief Investment Officer

Mann Bioinvest

Andy Smith is chief investment officer of Mann Bioinvest. Mann Bioinvest manages the Magna BioPharma Income fund, a global life science investment fund. Dr Smith was once a scientist and trained as a molecular microbiologist at the …

Anna Kress - Scientific Officer

m2p Labs

Annelise Soulier - Senior Scientist

Prokarium

Annelise joined Prokarium in 2013 as senior scientist to develop Prokarium’s leading travellers’ diarrhoea vaccine, Typhetec and a Clostridium difficile vaccine supported by a UK government grant in Synthetic Biology. Since the recent success of Typhetec’s preclinical …

Antonio Regalado - Senior Editor

MIT Technology Review

Antonio is the senior editor for biomedicine at MIT Technology Review, MIT’s magazine. He’s been scooping news about major advances in biotechnology since 1995 and has worked previously as the science reporter at the Wall Street Journal, …

Antony Evans - Chief Executive Officer

TAXA

Antony has an MBA with Distinction from INSEAD, an MA in Maths from the University of Cambridge and is a graduate of Singularity University’s GSP program. He is both a Louis Frank and Oppidan scholar and worked …

Arnab Chatterjee - Group Strategy Manager

Shell

Arnab has been working for over a decade to create better energy or materials solutions. His focus has been on creating and developing technology on one hand, and devising effective strategy and thought leadership on the other. …

Arturo Elizondo - CEO

Clara Foods

Arturo Elizondo is CEO of Clara Foods, a performance ingredients company making the world’s first animal-free egg white. Prior to joining Clara Foods, Arturo served under Supreme Court Justice Sonia Sotomayor, the U.S. Department of Agriculture, and the investment bank …

Arvind Gupta - Founder & SOSV General Partner

IndieBio

Formerly Design Director of Product Development and Strategy at IDEO and co-founder of fitness startup Starters, Arvind brings over a decade of experience in helping startups and Fortune 50 companies launch new tech products. He plays a …

Austen Heinz - Chief Executive Officer

Cambrian Genomics

CEO at Cambrian Genomics; EECS Seoul National Korea, Trinity College Duke. First in the world to use lasers to retrieve sequence verified DNA.

Axel Trefzer - R&D Leader Synthetic Biology

Thermo Fisher Scientific

Axel Trefzer received his PhD in Microbiology from the University of Tübingen, Germany. He started his industrial career with Diversa Corporation followed by positions of increasing responsibilities at Invitrogen and DSM. In 2011 he joined Lifetechnologies (now …

Axel Trefzer - Research and Development

Thermo Fisher

Axel Trefzer received his PhD in Microbiology from the University of Tübingen, Germany. He started his industrial career with Diversa Corporation followed by positions of increasing responsibilities at Invitrogen and DSM. In 2011 he joined Lifetechnologies (now …

Barbara Harvey -

Novozymes

Basil Omar - Chief Commercial Officer

CHAIN Biotechnology

Basil has a PhD in Physics from Loughborough University and MBA from Warwick Business School and held senior technology development and management roles in semiconductors, electronic displays and advanced materials with Phillips Electronics and Sharp Corporation. Spent …

Beatriz San Martin - IP Specialist

Fieldfisher

Beatriz is an IP specialist, with a focus on the life sciences sector and emerging/disruptive technologies. Prior to pursuing a legal career, Beatriz was a scientist with a degree and a Wellcome Trust PhD and postdoc from …

Belinda Clarke - Lead Technologist

Technology Strategy Board

Belinda is the Lead Technologist for synthetic biology at the Technology Strategy Board, the UK’s innovation agency. Here, she has responsibility for the programme of activities designed to support the growth of a successful UK synthetic biology …

Ben Reeve - CTO

CustoMem

Ben is a synthetic biologist and the CTO of CustoMem Ltd. He completed his PhD in the Ellis Lab at Imperial College where his research focused on genetic toolkit development for engineering non-model organisms. He was a …

Benjamin Griffin - Senior Director of Microbial and Enzyme Engineering

Synthetic Genomics

Benjamin Griffin is the Senior Director of Microbial and Enzyme Engineering for the Nutritional and Bio-industrial Products Division at Synthetic Genomics, Inc.  He is a microbial physiologist and received his PhD from Michigan State University in Microbiology …

Bethan Wolfenden - Founder

Bento Bio

Bethan co-founded Bento Bio, which aims to create a participatory and creative future for synthetic biology. In addition, Bethan is an iGEM veteran and a synthetic biology PhD student in London, UK. She has an undergraduate degree …

Bill Liao - Venture Partner

SOSventures

Diplomat, investor, entrepreneur, business mentor, speaker and author, Bill Liao co-founded the business social network service XING and is a venture partner at SOSventures, a global venture capital firm and investment management firm. Bill is a special …

Birgit Wiltschi - Head of the Synthetic Biology Group

acib – Austrian Centre of Industrial Biotechnology

Dr. Birgit Wiltschi is the head of the Synthetic Biology Group at the Austrian Center of Industrial Biotechnology – acib in Graz, Austria. Her research focuses on the engineering of proteins with unnatural amino acids and the …

Blake Byers - General Partner

Google Ventures

Blake is a general partner at Google Ventures and continues to direct research at Stanford University in optogenetics and stem cell biology. Blake has a background in engineering and investing and helped start two companies out of …

Boet Glandorf - Senior Risk Assessor

RIVM/VSP

Boet Glandorf,  at the Dutch GMO Office, National institute of Public Health and the Environment. After earning her doctorate in plant pathology and performing field trials with GM biocontrol bacteria for several years, she gained her current …

Brandon Chen - Senior Research Scientist

Genomatica

Brandon Chen is the lead of strain engineering automation at Genomatica and one of the key contributors of 1,4-butanediol strain development that led to the successful commercialization of the renewable chemical. In the past four years, Brandon has …

Breton Hornblower -

New England Biolabs

Breton Hornblower is the Product Marketing Manager for New England Biolab’s portfolio of products related to RNA biology, genome editing and synthetic biology. New England Biolabs is a leading supplier of recombinant enzymes for molecular biology applications. …

Brian Bramlett - Strategist

Intel

Brian is a strategist, design, and entrepreneur with over 25 years in technology and life sciences. He works in the silicon and architecture planning team for the New Technology Group at Intel, and is responsible for driving …

Brian Frezza - Co-Founder & Co-CEO

Emerald Therapeutics

Brian M. Frezza is Co-founder and Co-CEO of Emerald Therapeutics, where he spearheads Emerald’s therapeutic research effort and is lead architect of the Emerald Cloud Lab (ECL), a remote controlled life science laboratory. Brian completed his PhD …

Brynne Stanton - Biological Engineer

Ginkgo BioWorks

Brynne Stanton joined Ginkgo BioWorks in January of 2014. At Ginkgo BioWorks, custom designed microbes are produced for a range of industries using an integrated technology platform including custom hardware, software, and wetware. As a Biological Engineer …

Camille Delebecque - Chief Executive Officer

SynBio Consulting

Camille has been advising organizations across the private, public and social sectors since his start with Synthetic Biology in 2006 and is the Founder and CEO of SynBio Consulting. Prior to founding SynBio, Camille worked at Puretech …

Carlo Quiñonez - Director of Research

FATHOM

As the Director of Research at FATHOM, Carlo Quiñonez coordinates internal and external research projects which are at the forefront of advanced manufacturing. He has twenty years of experience in additive manufacturing, prototyping, product design, and electrical …

Carlos Olguin - Research Scientist

Autodesk Research

Carlos formed the Bio/Nano/Programmable Matter Group at Autodesk Research in 2010. Carlos is a Research Scientist investigating the design spaces enabled by matter programming across domains and scales by collaborating with researchers around the world to co-envision …

Carrie McMahon -

Dr. Carrie (Hendrickson) McMahon earned her B.S. in Biology from Drew University (1994) and her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania (2002). After earning her doctorate, she began her federal career as …

Cathal Garvey - Scientific Director

IndieBio

Cathal Garvey is an independent synthetic biologist and co-founder of f FormaBiolabs. His personal mission is a vibrant, democratised platform for biotechnology. This will allow anyone, even those without training, to explore and possibly improve the living things that surround and support them. …

Catherine Barton - ‎Environmental Engineer

Dupont

Catherine A. Barton has worked at DuPont since 1989 and has served as an engineer in their Issues and Crisis Management in Public Affairs since 2011. Dr. Barton leads DuPont’s Biotechnology Issues Council and has also been …

Catherine Coleman - Astronaut

NASA

Dr. Catherine Coleman is a NASA Astronaut with more than 180 days in space, accumulated during two space shuttle missions and a six-month expedition to the International Space Station (ISS).  She launched and landed aboard the Russian …

Celia Caulcott - Executive Director, Innovation and Skills

BBSRC

Dr Caulcott is BBSRC Director, Innovation and Skills. Trained initially in microbiology and following her PhD she joined Celltech Ltd, where she worked on and subsequently led research on therapeutic recombinant monoclonal antibodies. After working for ICI …

Chantal Yue Shen -

BGI

Chantal Yue Shen is currently a PhD student of Dr. Patrick Cai and Dr. Chris French. She received a bachelor degree of Bioengineering from South China University of Technology (China) and a master degree of Biomedical Engineering …

Charles Fracchia - Founder

BioBright

Charles Fracchia is an IBM PhD Fellow at the MIT Media Lab in Joe Jacobson’s Molecular Machines group, and in the Church lab at the Wyss Institute at Harvard Medical School. Charles obtained his bachelor’s degree at …

Charlie Liu - Vice President

Cathay

Charlie Liu joined Cathay Industrial Biotech in 2010 and currently serves as Vice President. From 2007-2010, he worked as a graduate student researcher at the U.S. Department of Energy’s Joint BioEnergy Institute. Charlie received a Bachelor of Science from Yale University …

Chen Yang - Professor

Shanghai Institutes for Biological Sciences

Chenli Liu - Professor

SIAT

Chenli Liu is a Professor in Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and the Director of the Center for Synthetic Biology Engineering Research of SIAT. Liu received his B.Sc. and M.Sc. degrees in Biochemistry and …

Cheryl A. Fragiadakis - Technology Transfer Department Head

Lawrence Berkeley National Laboratory

Cheryl A. Fragiadakis heads Technology Transfer and Intellectual Property Management at the Lawrence Berkeley National Laboratory, which is operated for the Department of Energy by the University of California. Berkeley Lab conducts unclassified research and development in …

Chris Corden -

Scottish Enterprise

Chris joined Scottish Enterprise in 2011 after a 30 year career in industry which covered two Life science start ups as well as  a variety of technical roles. He has expertise in biorefining and currently is the …

Chris Redhead - Managing Director

Aruwon

Dr. Chris Redhead is Managing Director of Aruwon Ltd, providing strategic advice and interim management, as well as securing partners and finance for life science SMEs. Chris was a founding partner of the life science investment banking …

Chris Thorne - Gene Editing Community Specialist

Horizon Discovery

Chris has been working at Horizon for four years, during which he has been responsible for the genetic validation of all cell lines in Horizon’s catalogue, has been part of the launch of Horizon’s diagnostic reference materials …

Christian Olsen - Field Application Scientist

Biomatters

Christian has been a Field Application Scientist at Biomatters for the past 2 years. He provides scientific support for the Geneious sequence analysis platform. First released in 2005, Geneious is one of the world’s leading bioinformatics platforms, …

Christina Agapakis -

Ginkgo Bioworks

Christina is a biologist, writer, and artist interested in microbes and the future of biotechnology. She collaborates with engineers, designers, artists, and social scientists to explore the many unexpected connections between microbiology, technology, art, and popular culture. During …

Christina Smolke - CEO

Antheia

Dr. Christina Smolke heads a world-leading research program in the areas of synthetic biology, yeast metabolic engineering, and biomolecular engineering. She has pioneered the development of yeast biosynthesis platforms for an important class of plant natural products …

Christine Gould - Head of Next Generation Engagement

Syngenta

Christine is the Founder of Thought For Food (TFF) and is Head of Next Generation Engagement at Syngenta.  In 2011, she created TFF to inspire, connect and empower the next generation of innovators to create breakthrough solutions …

Christopher Voigt - Professor of Biological Engineering

MIT

Christopher Voigt, PhD is a Professor of Biological Engineering at MIT. He is the Co-Director of the Synthetic Biology Center and co-founder of the MIT-Broad Foundry. He is the Editor-in-Chief of ACS Synthetic Biology. He holds joint …

Claes Gustafsson - Chief Commercial Officer

DNA2.0

As DNA2.0’s Co-Founder and CCO, Claes’ main focus is to connect the DNA2.0 technology with commercial applications in need of data driven bioengineering. Prior to founding DNA2.0 in 2003, Claes was at Maxygen leading their bioinformatics team, …

Clive Smith - Principal Scientist

Sphere Fluidics

Clive Smith read Chemistry at University College Cardiff (B.Sc., 2.1, Honours, 1980) and completed a synthetic chemistry Ph.D. there under Dr Garry Procter (1980-3). He completed two post-doctoral fellowships, first at the Imperial Cancer Research Fund (1983-5) …

Connor Dickie - Chief Executive Officer

Synbiota

Connor Dickie is a multi patent-holding inventor and entrepreneur with a deep interest in media and technology. Connor co-founded Synbiota to accelerate the development of new medicines, materials, food and fuel by combining Synthetic Biology and the …

Conny Scheitz - Principal Research Scientist

Autodesk

Cornelia (Conny) Scheitz is a Principal Research Scientist in the Bio/Nano Research group at Autodesk. She focuses on building next generation design tools for synthetic biology. In addition to her expertise in molecular biology, cancer genetics and …

Constance John - Founder and CEO

MandalMed

Constance M. John, R.Ph., Ph.D., is the Founder and CEO of MandalMed, Inc. Dr. John holds a B. S. in Pharmacy from the University of Minnesota and a Ph.D. in Pharmaceutical Chemistry from UCSF. In addition to …

Corey Huck -

Intrexon

Mr. Huck joined Intrexon as Senior Vice President — Food Sector in October 2015. Mr. Huck brings to Intrexon over two decades of experience in agriculture and crop protection. Prior to joining Intrexon, he spent 22 years …

Curt Becker - Co-Founder

Molecular Assemblies

After leaving the Caruthers Lab at CU Boulder where the phosphoramidite DNA synthesis process was invented, Curt joined the founding team at Applied Biosystems and played a key role in commercialization of the first DNA synthesis generation. …

Dan Gibson -

SGI-DNA

Dr. Gibson, inventor of Gibson Assembly®, joined SGI in February of 2011 after spending more than six years at the J. Craig Venter Institute (JCVI) where he co-led the team that constructed the first synthetic bacterial genome …

Dan Widmaier - Chief Executive Officer

Bolt Threads

Dan Widmaier is the CEO and founder of Refactored Materials, Inc. He has led the company through four years of technology development, growth and financing. He earned his Ph.D. in 2010 in Chemistry and Chemical Biology, specializing …

Dana Heldt - Research Manager

CHAIN Biotechnology

Dana is the Research Manager at CHAIN Biotechnology Ltd, a healthcare biotech company developing Clostridium bacteria for novel high-value healthcare products. Dana obtained her PhD in Biochemistry from Queen Mary University of London and gained experience on …

Daniel Grushkin - Director of Cultural Programs at Genspace

Daniel Grushkin is a freelance journalist who covers the intersection of biology, culture and business. His articles have appeared in The New York Times, Businessweek, National Geographic Adventure, Popular Science, and Scientific American. In 2009, he co-founded …

Darren Platt - Vice President Data Science

Amyris

Dr. Platt leads Automation and Computing at Amyris, which provides data, software and robotics support across R&D.   Prior to Amyris, he was Director of Research at 23andMe, Head of Informatics at the Department of Energy’s Joint Genome …

David Berube - Research Professor

North Carolina State University

David M. Berube, Ph.D. is a Research Professor of Communication at North Carolina State University (NCSU) in science and technology communication. He teaches graduate seminars in persuasion, risk communication, disaster communication, and climate change communication. Dr. Berube …

David McElroy - Chief Business Officer

Ingenza

Dr David McElroy is Chief Business Officer at Ingenza. He was a co-founder of the agbio startup Nova Synthetix (RTP, NC), and natural gas to chemicals start-up, Calysta (Menlo Park, CA). He was previously the President of …

David Venables - CEO

Synpromics

Dr David Venables is currently CEO of Synpromics Ltd, a synthetic biology company developing promoters to enable controlled gene expression in support of gene and cell therapy applications and has recently completed two successful fund raising rounds …

David W McClymont -

SynbiCITE

David completed his PhD in Molecular Pharmacology at the University of Nottingham and subsequently moved to Xention Discovery to carry out assay development using automated patch clamp systems for ion channel drug discovery. This led to a …

David Wernick - Fulbright Research Scholar

Weizmann Institute of Science

Dave is a metabolic engineer designing bioprocesses for a sustainable future. He collaborated with Mitsubishi to convert waste manure into gasoline and organic fertilizers, and now investigates synthetic carbon fixation as a Fulbright Scholar at the Weizmann …

Davide De Lucrezia - CEO

Explora Biotech

Davide De Lucrezia is currently the CEO of Explora Biotech Srl, a biotech dynamic company he co-founded in 2006 and adjunct professor in Bio-nanomaterial at University Ca Foscari Venezia. Until 2012 he served as operative coordinator of …

Dean Falb - Chief Technology Officer

Synlogic

Dean Falb, CTO of Synlogic, Inc. is responsible for platform technology development and therapeutic program initiation. Previously, Dean was an entrepreneur in residence at Atlas Ventures and worked on several of its emerging portfolio companies. Prior to …

Debra Conway - Sales Manager

CyBio Northern Europe

Sales Manager at CyBio Northern Europe.

Deepti Tanjore -

Deepti is a Research Scientist at the Advanced Biofuels (and Bioproducts) Process Demonstration Unit (ABPDU) studying integrated biological and chemical pathways to generate bio-based products including biofuels, biochemicals, food proteins, biomaterials etc. Her research focuses on improving bioprocess …

Dek Woolfson - Professor of Chemistry and Biochemistry

BrisSynBio, University of Bristol

Prof Dek Woolfson took his first degree in Chemistry at the University of Oxford, UK. He then did a PhD at the University of Cambridge followed by post-doctoral research at University College London and the University of California, Berkeley. …

Denver Dale - Chief Executive Officer

On-Point Capital

Denver Dale, Ph.D. is the founder and CEO of On-Point Capital LLC, an investment management firm that provides highly specialized investment services to a select group of significant investors. In this capacity, Denver sets overall strategy for …

Derek Greenfield - Chief Executive Officer

Industrial Microbes

Derek Greenfield is a strain engineer and synthetic biologist at LS9, a technology leader in the development of sustainable fermentation-derived chemical products. He was a founding member of the LS9 team that designed and built commercial strains of …

Derek Wells - Senior Scientist

DuPont Industrial Biosciences

Dr. Wells is a senior scientist at DuPont Industrial Biosciences, and has expertise in microbiology, metabolic pathway engineering, and protein engineering for a diverse array of industrial applications.  He currently leads the molecular biology team involved in …

Devin Leake - Vice President of Research & Development

Gen9

Devin Leake hails from Thermo Fisher Scientific, where he spent 11 years, most recently as the Global Director of Molecular Biology R&D, overseeing research in enzyme development and nucleic acid chemistry and biology. Initially, Devin worked at …

Dirk Loeffert - CEO

BioMillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the …

Doug Hershberger - Associate Director, Bioinformatics

Algenol Biofuels

Over the course of his career, Dr. Hershberger has worked for, or collaborated closely with many of the leading industrial and renewable chemicals and fuels companies, including Dow Chemical, Genomatica, LS9, and Codexis. As associate director of …

Douglas Densmore - Founder

Lattice Automation

Douglas Densmore received his Bachelors of Science in Engineering (Computer Engineering) from the University of Michigan in April 2001. He received his Masters of Science in Electrical Engineering in May 2004 and his PhD in Electrical Engineering …

Douglas Friedman -

Engineering Biology Research Consortium

Douglas Friedman is Executive Director of the Engineering Biology Research Consortium (EBRC), a not-for-profit research consortium which aims to be the leading organization bringing together an inclusive community committed to advancing biological engineering to address national and global needs. …

Dr. Zhiming Cai - MD, PhD

Shenzhen Second People's Hospital

Dr. Zhiming Cai holds Doctoral Degrees in both Medicine and Management, he is currently appointed as Professor and Chief physician at Department of Urological Surgery in the First Affiliated Hospital of Shenzhen University / Shenzhen Second People’s …

Drew Endy - Professor

Stanford

Drew Endy developed the world’s first “fabless” genetic engineering teaching lab in the new Bioengineering program at Stanford and previously helped start the Biological Engineering major at MIT. His Stanford research team develops genetically encoded computers and …

Dror Berman - Managing Founding Partner

Innovation Endeavors

As the founding Managing Partner of Innovation Endeavors, Dror seeks diverse, creative ways to partner with entrepreneurs who are applying emerging technologies to re-shape industries globally. Throughout his career, Dror has been passionate about how entrepreneurial ecosystems …

Eben Bayer - CEO and Co-Founder

Ecovative

Eben uses biology to create disruptive solutions that are good for people and the planet. He has evangelized a strategy of bio-adaption around the world, including presentations at TED Global, PopTech, and Davos.  Eben is the CEO …

Edward Amento - Executive Director

Molecular Medicine Research Institute

Dr. Edward P. Amento, founder of the Molecular Medicine Research Institute and co-founder and executive officer of several biopharmaceutical companies, is an internationally recognized expert on the cellular and molecular biology of connective tissue disorders. He currently …

Edward Green - Chief Scientific Officer

Green Biologics

Edward gained a Ph.D. in Biochemical Engineering from the University of Manchester Institute of Science and Technology (UMIST) in 1993. Edward spent five years in academia at Rice University, Texas, US and at Gothenburg University, Sweden developing …

Edward Perello - Founder & Chief Business Officer

Desktop Genetics

Edward is founder and Chief Business Officer at Desktop Genetics, and looks to build a world where advanced biotechnologies can be used with ease. At Desktop Genetics, Edward is working to redefine how scientists use CRISPR technology …

Edward Silva -

Edward Silva is the Executive Director of Thought For Food (TFF), a unique non-profit innovation platform that empowers brilliant students globally to generate bold, new solutions that tackle the world’s food issues. Currently comprised of more than …

Edward You - Supervisory Special Agent

FBI

Edward You is a Supervisory Special Agent in the FBI’s Weapons of Mass Destruction Directorate, Biological Countermeasures Unit. Mr. You is responsible for creating programs and activities to coordinate and improve FBI and interagency efforts to identify, …

Elena Brevnova - Founder

Secrilico

Dr. Elena Brevnova is a founder of Secrilico, a company that intends to help molecular biologists optimize protein expression more quickly and at much lower cost. In parallel Dr. Brevnova is leading the Strain Engineering team at …

Eli Groban -

Autodesk

Eli leads the science in the BioNano group at Autodesk. He is regarded as an Industry leader in the development of operational scientific teams integrating metabolic engineering, software, DNA fabrication, and automation to produce awesome new biological …

Elizabeth Clarke - Chief Technology Officer

Industrial Microbes

Elizabeth Clarke is a co-founder and the CTO of Industrial Microbes, a synthetic biology start up that is developing new ways to convert natural gas into industrial chemicals. She was a founding member of theteam that built …

Elizabeth Iorns - Chief Executive Officer

Science Exchange

Dr. Elizabeth Iorns is co-founder and chief executive officer of Science Exchange, the online marketplace for science experiments. The mission of Science Exchange is to improve the efficiency of scientific research by making it easy for researchers …

Elizabeth Nickerson - Senior Manager of Product Applications and Technical Support

Gen9

Elizabeth Nickerson joined Gen9, Inc. in Cambridge, Massachusetts in July 2013 as the Senior Manager of Product Applications and Technical Support.  Elizabeth’s experience with novel high throughput DNA technologies began in applications development at next generation sequencing …

Ellen Jorgensen - Executive Director

Genspace NYC

Dr. Ellen Jorgensen is co-founder and director of Genspace, a nonprofit community laboratory dedicated to promoting citizen science and access to biotechnology. In 2011 she initiated Genspace’s award-winning curriculum of informal science education for adults, and in 2014 Genspace …

Elliot Roth -

Spira

Elliot founded Spira to tackle the problem of access to healthy food worldwide. Trained at Stanford’s d.School, Elliot brings years of experience as a consultant designing medical products, building communication platforms and business strategy. After experiencing hunger firsthand, he started …

Elsa Sotiriadis - Programme Director at RebelBio

SOSV

Elsa is a technologist, poet and director of the ’Moonshot Factory’ RebelBio at SOSventures. As Synthetic Biology PhD Scholar at Imperial College London and Hong Kong University, she did research on programmable DNA architectures (aptamers) for novel …

Emily Hicks - Founder

FREDsense Technologies

Emily Hicks, born and raised in Calgary, has been heavily involved in the iGEM competition since the beginning of her undergraduate degree. First recruited as a team member in 2009, Emily became passionate about synthetic biology and …

Emily Leproust - Chief Executive Officer

Twist Bioscience

Dr. Emily Leproust serves as CEO, co-founder and director of Twist Bioscience. As an early pioneer in the high throughput synthesis and sequencing of DNA, Dr. Leproust desires to disrupt the current process of gene synthesis to …

Ena Cratsenburg - Senior Vice President, Consumer Sector

Intrexon

Ena Cratsenburg brings to Intrexon over two decades experience in leading portfolio development and collaboration strategies for a number of consumer product businesses including cosmetics, flavors and fragrances, food and beverage, and nutritional health markets, as well …

Eric Steen - Chief Executive Officer

Lygos

Eric Steen is committed to developing cost and performance advantaged chemicals using synthetic biology. Eric holds a PhD in bioengineering from UC-Berkeley and a minor in Management Technology from Haas School of Business, UC-Berkeley. Eric is an expert in …

Eric Steinmetz - Senior Scientist

Lucigen

Eric Steinmetz is a Senior Scientist at Lucigen developing cloning and expression technologies. Prior to joining Lucigen, Dr. Steinmetz studied mechanisms of RNA synthesis and termination.  

Eric Ward - Co-CEO

AgBiome

Eric is Co-CEO of AgBiome, Inc., which discovers and develops novel biologicals and trait products for agriculture. He has worked in the ag biotech industry for 25 years, most recently serving as president of the Two Blades …

Esther Dyson - Founder

HICCup

Esther Dyson(@edyson) is chairman of EDventure Holdings and founder of HICCup, Health Initiative Coordinating Council.  HICCup has just launched The Way to Wellville (@WaytoWellville), an open-source, evidence-generating project devoted to defining and testing models for producing community …

Ewa Lis - Founder & CTO

Koliber Biosciences

Ewa Lis is the founder and CTO of Koliber Biosciences, a synthetic biology start up that utilizes data science approaches to enable more predictive engineering of microbes as biochemical production platforms. Before embarking on an entrepreneurial adventure …

Farzad Haerizadeh - Director, Genome Editing & Genome Engineering, Immuno-Oncology

Intrexon

Synthetic Biology lead R&D at Life Technologies in Carlsbad, California, Dr. Farzad Haerizadeh, along with his team, are developing synthetic biology parts, devices and chassis for a variety of organisms with industrial and medical values including algae, yeast, bacteria …

Florencio Mazzoldi - BioNano Research Group

Autodesk

Florencio Mazzoldi leads the software development efforts within the BioNano Research Group at Autodesk. He joined Autodesk Research in 2012 and his areas of expertise include software architecture, cloud technologies, software development process and bionanotechnology. Since 2000, …

Freedanz Ferdinandz - Chief Executive Officer

Morph Bioinformatics

Freedanz Ferdinandz is the Chief Executive Officer and Co-founder of Morph Bioinformatics – an iGEM start-up aiming to become a hub offering software solutions, mobile apps and a social platform for bioscientists and bioinformaticians. He has completed his degree …

Ganesh Kishore - Managing Partner

Spruce Capital Partners

Dr. Kishore has a distinguished track record of accomplishments in biotechnology research and development and business. He left DuPont in 2007 where he was Chief Biotechnology Officer to join Malaysian Life Science Capital Fund (MLSCF) as its …

Gary Carter - Director of Market Research

Agilent Research Labs

Gary Carter is currently the Director of Market Research for Agilent Research Labs with responsibilities in the areas of market landscaping and strategic planning. Prior to Agilent, Mr. Carter was the Principal of Stratagem Market Research, a …

Genya Dana -

Genya V. Dana is a Senior Science Policy Officer in the Office of the Science and Technology Adviser to the Secretary of State, at the U.S. Department of State in Washington, DC. She advises on emerging biotechnologies …

Geoffrey von Maltzahn - New Venture Principal

VentureLabs

Geoffrey von Maltzahn is a New Venture Principal within VentureLabs, the Flagship Innovation Foundry, where he focuses on inventing technologies and founding companies to address global challenges in nutrition, environmental sustainability, and medicine. Geoff has over a …

George Church - Professor

Harvard & MIT

George Church is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Center on …

George Guo-Qiang Chen - Professor

Tsinghua University

Professor George Guo-Qiang CHEN received his BSc and PhD from South China University of Technology in 1985 and Graz University of Technology (Austria) in 1989, respectively. He also conducted research in 1990-1994 as a postdoc at University …

Gernot Abel - Science Manager

Novozymes

Gernot J. Abel is Science manager and Innovator in Novozymes. Throughout his career he has been paving the way for a green economy with more sustainable growth using solutions found in nature and matured in the laboratory. …

Giacomo Bastianelli -

Giacomo Bastianelli holds a PhD in bioinformatics from the Pasteur Institute in Paris and a M.Sc. in Pharmaceutical Biotechnology from the University of Bologna (California, Barcelona). Giacomo is a young entrepreneur/executive who founded and managed biotech and high-tech companies (Meiogenix, …

Giles Ochs - Co-Founder

Metamixis

Giles is a co-founder at Metamixis, which aims to deliver sensitive, cheaper, and faster chemical measurements to help bolster the bioeconomy.

Guy-Bart Stan - Associate Professor

Imperial College London

Guy-Bart Stan is a Reader (Associate Professor) in “Engineering Design for Synthetic Biology” and the head of the “Control Engineering Synthetic Biology” group at the Centre for Synthetic Biology and Innovation (CSynBI) and the Department of Bioengineering …

Hadyn Parry - Chief Executive Officer

Oxitec

Hadyn is the CEO of Oxitec. Hadyn has an extensive background in the Life Science sector. He has operated in both agricultural and pharmaceutical sectors at senior levels, and in both multinationals and SMEs. Hadyn was also …

Hans Genee - Co-Founder and CSO

Biosyntia

Hans Genee, PhD did his doctoral degree in biotechnology at the NNF Center for Biosustainability at the Technical University of Denmark with additional training from Harvard University in the group of Professor George Church and from UC Berkeley …

Hansjoerg Haas - Senior Director and General Manager of Laboratory Automation

Thermo Fisher

Dr. Hansjoerg Haas is Senior Director and General Manager of Laboratory Automation at Thermo Fisher Scientific. Haas received his PhD. from the Justus Liebig University, department of Biochemistry, Germany in 1993. Throughout his 25 year career he …

Harry Yim - Director of Strain Engineering

Genomatica

Harry Yim is Director of Strain Engineering at Genomatica Inc., a leader in sustainable chemicals: Genomatica delivers new manufacturing processes that enable its partners to produce the world’s most widely-used chemicals from renewable feedstocks, with better economics …

Helge Holm-Larsen - Director, Business Development

Biogasol

Helge Holm-Larsen has a MSc in chemical engineering from the Technical University of Denmark. Besides, he has a degree in international trade from Copenhagen Business School. Helge has specialized in business development within new energy conversion technologies including …

Helge Zieler -

Helge Zieler founded Primordial Genetics in 2011 with the goal of building the premier company for creating advanced microbial production systems. Helge obtained his PhD in yeast genetics with Nobel Laureate Paul Berg at Stanford University. He …

Hemai Parthasarathy - Scientific Director

Breakout Labs

Hemai Parthasarathy is Scientific Director of the Thiel Foundation and its program to support early-stage, radical science-based companies, called Breakout Labs. She is responsible for establishing the scientific priorities of the program, evaluating submitted proposals, and monitoring …

Henrik Hagemann - CEO and Co-Founder

CustoMem

Henrik is co-founder of CustoMem, where they engineer organisms to produce selective membranes that capture hazardous chemicals in industry water. He completed his MEng studies at Imperial College London where his research included a genetic toolkit for …

Henry Lee - CoFounder/Research Fellow

glotta/Harvard University

Henry received his BS in Electrical Engineering from the University of Washington where he did research in FPGAs (field programmable gate arrays) and became interested in the notion of reconfigurable computing. Realizing that cells could be leveraged …

Hermann Hauser - Co-founder

Amadeus Capital Partners

In 2015 Hermann was awarded an KBE for services to Engineering and Industry. Serial Entrepreneur and Co-founder of Amadeus Capital Partners, Dr Hermann Hauser KBE has wide experience in developing and financing companies in the information technology …

Hongzhi Tang - Professor

Jiao Tong University

Huw Jones - Professor

Rothamsted Research

Huw D Jones PhD, CBiol. FSB. is a Professor at the Dept. Plant Biology & Crop Science, Rothamsted Research. Huw’s laboratory occupies a leading position in the development of cereal genetic transformation systems and the application of transgenic approaches to …

Ian Archer -

IBioIC

Dr Ian Archer joined IBioIC as Technical Director in August 2015, Ian is tasked with shaping the IBioIC’s strategy and implanting the business plan for the centre. Specifically, he identifies mechanisms, resources and techniques for solving industry …

Ian Fotheringham - Managing Director

Ingenza

Ian Fotheringham received a B.Sc. and Ph.D. in Molecular Biology from the University of Glasgow, UK in 1986. He then joined the NutraSweet division of Monsanto in Chicago, USA, constructing microbes to produce the Aspartame® sweetener. From …

Ian Hanegraaff - President

Analytik Jena US

Ian Hanegraaff, head of Analytik Jena US, works daily with both partners and current clients to increasingly elevate the user experience of their automated solutions with the mission of one day making the tools that allow for …

Ilan Wapinski - Director of Development

enEvolv

Ilan Wapinski is the Director of Development at enEvolv where he leads the development of the company’s strain engineering platform. Prior to joining enEvolv, Dr. Wapinski was a Systems Biology Fellow at Harvard Medical School, where he …

Immanuel Sanka - Founder

SynBio UGM

Immanuel Sanka is an undergraduate student at Universitas Gadjah Mada in Indonesia, studying synthetic and systems biology. An active researcher, he specializes in marine science. He is co-founder of SynBio UGM, an open source platform with a Do-It-Yourself …

Ipshita Mandal - Head of Business Development

Bactevo

Ipshita Mandal serves as the Head of Business Development at the fast growing Cambridge biotech company Bactevo. At Bactevo, she is currently leading the business development strategy which has developed a TarGET platform that unlocks the full …

Irina Makkaveeva - Co-founder

protocols.io

Irina is a co-founder of protocols.io. She has an MBA from UCLA Anderson School of Management and several years of industry work experience. Prior to business school Irina worked as software engineer and research analyst in the …

Isabel Rocha - Chief Scientific Officer

SilicoLife

Isabel Rocha is the CSO of SilicoLife, a company focused on developing improved microbial strains for industrial applications using in silico methods. She did her PhD in Chemical and Biological Engineering at Minho University in Portugal and …

Itschak Friedman - Venture Partner

LionBird

Itschak Friedman is currently a Venture Partner at LionBird and runs the Advising Founders team, applying his vast experience to coaching the portfolio companies from technological road map development through first sales and delivery. Previously Itschak served …

J. Craig Venter - Chief Executive Officer

Synthetic Genomics

J. Craig Venter, Ph.D., is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is Co-Founder and CEO of Synthetic Genomics Inc. (SGI), a privately …

Jack Bobo - Senior Advisor on Food Policy

U.S. Department of State

Jack Bobo is a Senior Advisor on Food Policy at the U.S. Department of State. Jack works at the intersection of science, law and policy related to agricultural trade, food security, climate change, and development. Prior to …

Jack Newman -

As Chief Science Officer, Jack built and managed the 100+ research team of Amyris, Inc., (NASDAQ:AMRS) a renewable products company he co-founded in 2004 with a grant from the Bill and Melinda Gates Foundation to produce a …

Jacqueline Quinn - Research Scientist

Autodesk Research

Jackie Quinn is a Research Scientist in the Bio/Nano/Programmable Matter group at Autodesk Research, and coordinates the group’s efforts toward creating an environment for designing biology on the Project Cyborg platform. Currently in restricted beta, Project Cyborg …

Jaleh Daie -

Aurora Equity

Jaleh Daie, Ph.D.  Women in Technology Hall of Famer and recipient of a US Congressional Citation, Dr. Jaleh Daie is a multifaceted and strategic leader with extensive board and executive experience in private and public sectors. She quickly scales into …

James Brown - Director

Synthetic Biology Special Interest Group

James is the Director of the UK’s Synthetic Biology Special interest Group (SIG), where he works to partner the UK’s research-base expertise in synthetic biology with relevant industrial communities and investment opportunities. Funded by the TSB and …

James Collins - Professor of Biological Engineering

MIT

James J. Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT, as well as a Member of the Harvard-MIT Health Sciences & Technology Faculty. He is also a Core …

James Craven - Head of Sample Management

TTP Labtech

James Craven has worked in the field of laboratory automation for 15 years and currently holds the title of Head of Sample Management at TTP Labtech and is responsible for the strategic direction of all products within …

James Field - Chief Executive Officer

LabGenius

James Field is LabGenius’ founder and the co-inventor of the company’s proprietary gene synthesis technology. James completed his PhD studies at Imperial College London where his research was focused on re-engineering protein nanocages for biotechnological applications. Prior …

James Schroeder - BioEntrepreneur & Intellectual Property Advisor

China Innovate

James Schroeder is a bio-entrepreneur and founder of one of China’s earliest synthetic biology companies. He has a degree in biology from Penn and studied genetics at Oxford University and law in Shanghai. He has seventeen years …

James Stirling - Provost

Imperial College

Professor James Stirling CBE FRS became the first Provost of Imperial College London in August 2013. Before joining Imperial, Professor Stirling was the Head of the Cavendish Laboratory at the University of Cambridge.  He completed an undergraduate degree in mathematics at …

James Taylor - CEO

Precision NanoSystems

James is the CEO and co-founder of Precision NanoSystems, Inc. (PNI), a commercial stage biotechnology company at the convergence of nanotechnology, genomics, and personalized medicine.  James has a B.A.Sc. in engineering physics from UBC and a Ph.D. in genetics from the …

Jamie Bacher - Chief Executive Officer

Pareto Biotechnologies

Having worked in both biofuels and therapeutics, Dr. Bacher saw the potential for application of underexploited chemistries to familiar problems, and founded Pareto Biotechnologies to utilize them in novel ways.Dr. Bacher has a history of initiating and …

Janet Bainbridge - Head of Agricultural Technology

UK Trade & Investment

On 1st August 2013 Janet was appointed Head of Agricultural Technology (Inward Investment) for UK Trade & Investment with  responsibility  for delivery of the investment imperatives within the UK agricultural technology strategy. Formerly a UKTI Technology Sector …

Jasmina Aganovic - President

AOBiome, Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a company developing products that restore and maintain good bacteria on the skin. Mother Dirt and it’s research partner, AOBiome, are pioneering the role of bacteria on the skin as …

Jason Kelly - Founder

Ginkgo BioWorks

Jason Kelly co-founded Ginkgo BioWorks in 2008. The organism is the product at Ginkgo BioWorks. Ginkgo’s organism engineers design microbes to spec for customers across a range of industries using an integrated technology platform including custom hardware, …

Jason King - Chief Executive Officer

Oxford Biotrans

Jason has fourteen years’ start-up/SME experience covering global business development, business leadership and project management, primarily in the catalysis, chemicals and advanced materials sectors. Previously Jason was Vice President for Business Development with Avantium Technologies in the …

Jason Potter - Scientist

Thermo Fisher Scientific

After graduating from Cornell, Jason has 20 years experience in biotech R&D. He has led development and evolution of enzymes including SuperScript III and other reverse transcriptase and polymerases at Invitrogen/Life Technologies. He has led groups focusing …

Jay Keasling - Chief Executive Officer

Joint BioEnergy Institute

Jay Keasling received his B.S. in Chemistry and Biology from the University of Nebraska in 1986; his Ph.D. in Chemical Engineering from the University of Michigan in 1991; and did post-doctoral work in Biochemistry at Stanford University …

Jay Konieczka - Chief Operating Officer & Cofounder

EnEvolv

Jay Konieczka, PhD, is the Chief Operating Officer and Cofounder of enEvolv, a pioneer in ultra-rapid whole genome engineering. He oversees enEvolv’s R&D operations and external collaborations. Prior to enEvolv, Dr. Konieczka was a Postdoctoral Fellow at …

JC Gutierrez-Ramos -

Dr. Gutiérrez-Ramos has over 20 years of drug discovery and development experience from leading global biopharmaceutical companies. He currently serves as Chief Executive Officer of Synlogic Inc. Previously, he served as Group Senior Vice President and global …

Jean-Paul Leonetti - Vice President of Research and Development

DEINOVE

Jean-Paul Leonetti, Director of R&D at Deinove, has been involved in the Deinove project since its inception. He is PhD in Biochemistry and Molecular Biology and was Research director at CNRS before joining Deinove. He is the author …

Jeffrey Dietrich - Chief Technology Officer

Lygos

Jeffrey Dietrich received his BS in Bioengineering from Rice University in 2005 and his PhD in Bioengineering from UC-Berkeley in 2011; Jeffrey was awarded a Siebel Scholarship in 2010 for his dissertation research in Dr. Jay Keasling’s …

Jeffrey Hung - Chief Commercial Officer

Vigene Biosciences

Jeffrey Hung, Ph.D, is the Chief Commercial Officer at Vigene Biosciences, a leader in the viral particle based gene delivery field. Dr. Hung, an innovative leader in growing startup companies, is instrumental for the continued growth which …

Jeffrey Kim - Co-Founder and CEO

Radiant Genomics

Dr. Jeffrey Kim serves as Co-Founder and CEO of Radiant Genomics, a functional metagenomics firm located in Emeryville, CA. He received his undergraduate degree in Molecular Biology from Princeton University, and his Ph.D. in Metagenomics from Rockefeller …

Jeffrey Marlow - Geobiologist

California Institute of Technology

Jeff Marlow is a graduate student in Geological and Planetary Sciences at the California Institute of Technology where he studies exotic microbial metabolisms and the mechanisms of energy aquisition in an attempt to understand the limits of …

Jeffrey Whitford - Director of Global Citizenship

Sigma-Aldrich

Jeffrey Whitford joined Sigma-Aldrich in 2005 and has served in a variety of positions most recently as the company’s first-ever Director of Global Citizenship.  In his latest role, Whitford is responsible for developing and implementing strategic programs …

Jemma Redmond - CEO & Founder

Ourobotics

Jemma Redmond has a background in engineering, applied physics and NanoBioScience. She has run her own businesses over the years in university and has a background in engineering. She is the founder of a startup called ourobotics which …

Jenny Rooke - Venture Partner

Fidelity Biosciences

Jenny Rooke brings a combination of strategy, operating, and investing experience to her work with life sciences companies, specializing in research tools, diagnostics, and synthetic biology. Dr. Rooke’s investing roles include Managing Director and founder at 5 …

Jerome Engel - Professor

UC Berkeley

Professor Jerome S. Engel is an internationally recognized expert in innovation, entrepreneurship, and venture capital, lecturing and advising business and government leaders around the world. A leading member of the University of California at Berkeley’s entrepreneurship faculty, …

Jiahao Huang - Co-Founder and Director

Nuclera Nucleics

Although born and raised in China, Jiahao attended University of California, Berkeley, USA, where he obtained a BSc in chemical biology. He went on to complete his PhD in Molecular Biology at the University of Cambridge, UK. …

Jim Haseloff - Professor

University of Cambridge

Jim Haseloff is a plant biologist working at the Department of Plant Sciences, University of Cambridge. His scientific interests are focused on the engineering of plant morphogenesis, using microscopy, molecular genetic, computational and synthetic biology techniques. Prior …

Jim Philp - Science and Technology Policy Analyst

OECD

Jim Philp (PhD) is a microbiologist who has worked as a policy analyst since 2011 at the OECD, specialising in industrial biotechnology, synthetic biology and biomass sustainability. He was an academic for about sixteen years researching environmental …

Jin Ngee Chia - Technical Support Officer

Integrated DNA Technologies

Jin Ngee is a veteran biologist. He spent time through the Dark Ages of biology doing manual radioactive sequencing, picking lambda phage plaques and then wasting much precious time trying to solubilize expressed proteins from E. coli inclusion bodies. He …

Joanna Dupont-Inglis - Director of Industrial Biotechnology

EuropaBio

Joanna Dupont-Inglis first joined EuropaBio, the European Association of Bioindustries, in February 2009 and in April 2011 was appointed Director of Industrial Biotechnology. Her work within EuropaBio involves developing a more supportive, predictable and coherent EU policy …

Joanne Channon - Programme Manager

Cambridge Consultants

Dr Joanne Channon is a Programme Manager at Cambridge Consultants, an innovative product development engineering and technology consulting firm. She earned her degree and a doctorate in Biophysics from the University of Cambridge. Prior to joining Cambridge …

Joel Cherry - President, Research & Development

Amyris

Joel Cherry currently leads Amyris research and development, including various ongoing collaborations. Prior to joining Amyris in 2008, Dr. Cherry was Senior Director of bioenergy biotechnology at Novozymes. During his tenure at Novozymes, he was a member …

John Collins - Commercial Director

SynbiCITE

John is commercial director of SynbiCITE, the UK national centre for commercialising synthetic biology – one of the ‘8 great technologies’ – which is based at Imperial College London, UK. For several years, John ran the UK’s …

John Cumbers - Founder

SynBioBeta

John Cumbers is the founder of SynBioBeta, an activity hub for synthetic biology startup companies, industry and investors. He received his PhD in Molecular Biology, Cell Biology, and Biochemistry from Brown University. He has a masters degree …

John Lesnick - Appllications Scientist

Labcyte

John has worked in the Drug Discovery and Development field for over 20 years.  He has contributed assay development expertise for many therapeutic areas from target validation to preclinical toxicology and has extensive knowledge in automation and …

John Melo - President and CEO

Amyris

John Melo has 30 years of combined experience as an entrepreneur and thought leader in the global fuels industry and technology innovation. Mr. Melo has served as our Chief Executive Officer and a director since January 2007 …

John Sgouros - Consultant

Biomax Informatics

John Sgouros is a biologist who moved to bioinformatics about 25 years ago. After a PhD in protein chemistry at the Max Planck Institute of Biochemistry in Munich, Germany, he joined the European Yeast Genome Sequencing Project …

John Sundman - Novelist

John Sundman is an essayist and novelist who has been writing about the convergence of digital and biological technologies for more than twenty years. His 1999 novel Acts of the Apostles has been called “the first great thriller of …

Jon Chesnut - Sr. Director, Synthetic Biology R&D

Thermo Fisher Scientific

Jon Chesnut received a PhD in Cell and Molecular Biology from UC Davis (1994), and did postdoctoral studies at the University of Colorado in recombinant antibody technology development (1994-95). Prior to graduate school, he was employed at …

Jonathan Kotula - Scientist

Synlogic

Jonathan Kotula is an entrepreneurial scientist who has conducted and commercialized basic research, co-founded a small device start-up and charity event. Jonathan is currently the Lead Synthetic Biologist at Synlogic where he is responsible for leading the …

Jonny Ohlson - Chief Executive Officer

Touchlight Genetics

Jonny founded Touchlight in 2007. His previous positions include: board director at Saatchi and Saatchi Advertising Ltd, Managing Director of Griffin Bacal Advertising, Chairman of the Institute of Practitioners in Advertising Society, main board director of Soho House …

Joseph Adams - Scientific Manager

GlaxoSmithKline

Joseph Adams PhD is a scientific manager within GlaxoSmithKline. He has 20 years of experience within the process research and development organisation. He obtained a PhD in organic chemistry from the University of Sheffield, before conducting postdoctoral work in …

Josh Gilmore - Course Developer and Instructor

SynBioBeta

Dr. Josh Gilmore received his PhD in Chemistry from University of California Berkeley in 2007 with Matt Francis while studying protein attachment to synthetic surfaces. He performed his postdoctoral work with Professor Jay Keasling at the Joint …

Joško Bobanović - Partner

Sofinnova

Joško Bobanović joined Sofinnova in 2010 as Partner of the Sofinnova Green Seed Fund dedicated to seed activities in green chemistry and bio-energy. Prior to joining Sofinnova he spent eight years in venture capital with iNovia Capital and …

Joy Ho Shu Fen - Research Engineer

A*STAR - Agency for Science, Technology and Research

Joy Ho Shu Fen is currently a graduate student reading Clinical Medicine at A*Star – University of Oxford joint programme. She received her undergraduate degree in Materials Engineering from Nanyang Technological University. She has previously worked at …

Joyce Tait - Director

Innogen Institute

Joyce Tait, PhD, is Director of the Innogen Institute, and a professor at the University of Edinburgh. She has an interdisciplinary background in natural and social sciences, covering agrochemical, pharmaceutical and life science industry sectors, focusing on: …

Jude Huggan -

IBioIC

Dr Jude Huggan joined IBioIC as Skills Programme Manager in May 2014 and was responsible for the design, delivery and implementation of all educational programmes and STEM initiatives offered through IBioIC, with the ultimate aim of the …

Juergen Mairhofer - CEO

enGenes Biotech

Juergen co-founded enGenes Biotech after working as a Research Associate at the intersection of genetic and bioprocess engineering at the University of Natural Resources and Life Sciences (BOKU), Vienna, Austria. Prior to this, he held a PostDoc …

Junbiao Dai - Associate Professor

Tsinghua University

Dr. Junbiao Dai received his Bachelors of Science from Nanjing University in 1993. He received his Master of Science in Biology in 2000 from Tsinghua University and his PhD in Molecular, Cellular and Developmental Biology in 2006 …

Justin Bingham - Director of Business Development

SGI-DNA

Justin Bingham is the Head of Business Development at SGI-DNA, Inc. a wholly owned subsidiary of Synthetic Genomics, Inc (SGI). He is a founding member of the SGI-DNA team that formed the SGI subsidiary 3 years ago. …

Kara Bortone - Head of Company Sourcing

JLABS

As Head of Company Sourcing for JLABS San Diego, Kara is actively building a pipeline of prospects and driving licensee companies through diligence, selection, and joining JLABS. Kara coordinates with the J&J Innovation Centers and J&J Development …

Karen Ingram - Designer

CUT/PASTE/GROW

Karen Ingram is a designer, artist and creative director who uses her skill set to promote scientific awareness. Ingram recently completed work with Natalie Kuldell (MIT) on visual elements for Biobuilder (O’Reilly, June 2015). Ingram is a …

Karl Handelsman - Founder

Codon Capital

Karl is a seasoned venture capitalist with over 15 years of experience investing in early stage biotechnology. Karl has worked with entrepreneurs from Idea to IPO as a trusted advisor and BOD member. Prior to his role …

Karl Sanford -

Dupont

Karl Sanford earned his Ph.D in chemistry from the University of Florida and then went to M.I.T studying under Professors George Whitesides and D.I.C. Wang; the work was focused on applying biotechnology to the production of fine …

Karsten Temme - Chief Executive Officer

Pivot Bio

Karsten Temme is CEO and co-founder of Pivot Bio, Inc., a company enabling genome-scale programming of microbes. He earned his PhD in Bioengineering from UC San Francisco, under Christopher Voigt. His graduate research focused on reprogramming nitrogen …

Kate Caves - Head of R&D

DNA2.0

Kate Caves is the head of the R&D group at DNA2.0 focused on optimizing mammalian expression.  Recognized as a vector engineering and genome engineering expert, Kate applies her background at DNA2.0 using machine learning technologies to efficiently …

Kate Caves - Head of Business Development & Marketing

DNA2.0

Kate Caves joined DNA2.0 in July 2013. As Head of Business Development and Marketing, she leads DNA2.0’s sales and marketing activities in building a successful track record for bridging technology and business development strategies to deliver high-quality …

Kate Hall - Managing Director

BIO

Kate Hall is the managing director for the Council for Biotechnology Information (CBI) and is responsible for CBI’s outreach efforts to positively impact acceptance of modern agricultural biotechnology in the United States. In this capacity Ms. Hall …

Kate Wildauer - Director of Operations and Education

SynBioBeta

Kate Wildauer received her bachelor’s in Business Administration from Villanova University and a Master’s in Microbiology from Thomas Jefferson University. Her 20 years experience includes positions in oncology research, clinical data coordination, project management, training, business development …

Kathryn Crossin -

Promosome

Dr. Crossin has studied gene expression as a consequence of cell adhesion in the nervous system and neuronal stem cells. She is a long-time collaborator of Promosome CSO Dr. Mauro. At Promosome, she coordinates scientific, legal, and …

Kathryn Owen - Healthcare Ventures Associate

Imperial Innovations

Kathryn Owen is a Healthcare Ventures Associate at Imperial Innovations, evaluating and investing in therapeutics, medical device and diagnostics opportunities from the Oxford-London-Cambridge triangle. Kathryn joined Innovations in 2009 and has worked on a number of early …

Katrin Burt - Managing Director

Syngenta

Katrin joined Syngenta Ventures in 2014. Previously Katrin spent ten years as a Partner at Intersouth Partners, a traditional venture capital firm based in Durham, North Carolina, with $780 million under management. At Intersouth Katrin focused on …

Kedar Pandya - Head of the Engineering

EPSRC

Kedar Pandya is Head of the Engineering theme, which is one of a number of capability themes in EPSRC. His particular brief is to stimulate and support ambitious engineering research for the long-term benefit of the UK. …

Kef Kasdin - Chief Executive Officer

Proterro

Named among “the top 100 people in the bioeconomy” for 2013 and among “the top 100 people in bioenergy” for two consecutive years (2011-2012 and 2012-2013) by Biofuels Digest, Ms. Kasdin has been involved in developing and …

Keira Havens - Executive Director

The One Sky Initiative

Keira Havens works to make biology unexpectedly beautiful, first through efforts to develop a color changing flower as CEO of Revolution Bio, and now as Executive Director of The One Sky Initiative, synthetic biology’s newest nonprofit. As part …

Kevin Gray - Vice President of Biobased Chemicals

BetaRenewables

Kevin A. Gray, PhD is the Vice President of Biobased Chemicals for BetaRenewables. BetaRenewables is a joint venture between Biochemtex, Texas Pacific Group and Novozymes. Dr. Gray is responsible for partnership development between BetaRenewables and companies developing …

Kevin Holden - Head of Synthetic Biology

Synthego

Kevin Holden is Head of Synthetic Biology at Synthego in Redwood City, California where he is responsible for integrating synthetic biology workflows, such as CRISPR genome engineering, into novel engineering and automation platforms. He has over 10 …

Kevin Munnelly - President and CEO

Gen9

Kevin has over 20 years’ experience with molecular biology, chemistry, software, instrument development, and statistical analysis. Prior to Gen9, he was a Leader and General Manager in the Next Generation qPCR business at Life Technologies where he …

Khai Jien Kong - Chief Technology Officer

Morph Bioinformatics

Kong Khai Jien is the Chief Technology Officer, Chairman and Co-Founder of Morph Bioinformatics – an iGEM startup aiming to provide automated lab solutions for biotech R&D. He is currently completing his PhD at the University College …

Kiersten Stead - Venture Principal

Monsanto Growth Ventures

Dr. Kiersten Stead is a Venture Principal at Monsanto Growth Ventures.  Monsanto is a leading global, agricultural company providing products to growers worldwide.  Monsanto Growth Ventures, through investment and partnership, encourages entrepreneurs and innovative start-up companies, to …

Kinkead Reiling -

Angel Investor

Kinkead Reiling co-founded Amyris, a leading company in Biofuels and Bio-Chemicals, in 2003 and served as Senior Vice President of Corporate Development until early-2011. While at Amyris, Dr Reiling, worked on corporate strategy and finance, government policy, …

Klaus Hentrich - Product Manager

TTP Labtech

Klaus Hentrich is a global product manager for TTP Labtech, who are a UK based developer and supplier of automation solutions for the life science market including sample management, small volume liquid handling and detection systems.

Kristin Ellis - Scientific Lead

Opentrons

Kristin Ellis is the Scientific Lead at Opentrons. She previously worked in scientific development and clinical trials for MD Anderson Cancer Center. Now, she leverages that experience to make scientific research more collaborative, reproducible and accessible, working …

KT Moortgat -

KT Moortgat enables the translation of life science technologies to companies and products, through startup incubation, investment decision making, and corporate development.  She is currently CEO of microbiome therapeutics company Osel Inc.  She has also provided executive-level …

Laurakay Bruhn - Section Manager of Biological Chemistry

Agilent Laboratories

Laurakay Bruhn is Section Manager of Biological Chemistry in Agilent Laboratories and manages programs and projects related to nucleic acid synthesis, genomics, proteomics and metabolomics as well as other efforts related to developing new technologies for research …

Lina Gasiūnaitė - Co-founder

Biotangents

Lina co-founded Biotangents with fellow Director and Lead Scientist Andy Hall-Ponsele in 2015 with the aim of using novel DNA manipulation technologies to solve societal challenges. Biotangents are now applying these technologies to the challenges of diagnosing …

Lindy Fishburne - Executive Director

Breakout Labs

Lindy Fishburne is the Executive Director of Breakout Labs and serves as the Senior Vice President for Investments at the Thiel Foundation. She leads the organization’s strategic development and program design. She joined the foundation in 2007 …

Ling Hua - Lead of Industrial Biosciences Research

Dupont

Dr. Hua obtained her Ph.D. from Rice University and she was a director of Molecular Biology at BioCatalytics, Inc. She has discovered more than 50 enzymes (biocatalysts) for pharmaceutical applications. Before she joined Genencor, she was the …

Lionel Clarke - Co-chairman

UK Synthetic Biology Leadership Council

Lionel Clarke is engaged in the planning and delivery of strategic research and technology programmes to Shell across the ‘biodomain’ (‘biofuels and other biotechnology applications’), deploying internal and external resources – including academic and industrial partnerships – …

Lisa Caproni - Senior Research Scientist

Touchlight Genetics

Dr. Lisa Caproni was educated at the University of Edinburgh where she completed a BSc and PhD in the area of infectious diseases with her doctoral research focussing on the effect of antibiotics on the virulence of the important …

Lisa Krieger - Journalist

San Jose Mercury News

Lisa M. Krieger is a journalist for The San Jose Mercury News and Bay Area News Group, covering science and medical news from Stanford University, the University of California, NASA-Ames, Lawrence Livermore Labs and other Bay Area-based …

Lord David Prior - Parliamentary Under Secretary of State

Department for Business, Energy and Industrial Strategy

Lord Prior of Brampton was appointed Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy on 21 December 2016. Previously he served at the Department of Health as Minister for NHS Productivity …

Louis Metzger - Principal Scientist

Novartis

Louis Metzger is a principal scientist in the Infectious Diseases division of Novartis, where he leads a project team endeavoring to discover novel antibiotics.  He is therefore acutely aware of the need to develop new chemical matter …

Mac Cowell -

Manylabs

Maciek Drozdz - Investment Manager

Entrepreneurs Fund

Maciek is an Investment Manager at Entrepreneurs Fund. Before joining EF he was an analyst at Atlas Venture in Munich and an Investment Director at MCI.Bioventures in Poland. Maciek holds an MSc in molecular biology from A. …

Mandy Vink - Director, Business Development

Codexis

Mandy Vink received her MSc in biochemistry from the University of Amsterdam in 1998. She went on to obtain her PhD in Synthetic Organic Chemistry from the same university in 2003 on the synthesis of functionalized N-heterocycles …

Marcelo Freitas - Secretariat of International Affairs

Embrapa

Marcelo Frietas, Embrapa, Secreteriat for International Affairs, Brazilian Agricultural Research Corporation – PhD on Microbiology at the Federal University of Minas Gerais (UFMG), began his career as a federal professor and currently works at the Brazilian Agricultural …

Marcelo Kern - Molecular Biologist/Biochemist

GlaxoSmithKline

Marcelo Kern graduated from Imperial College London in 2007, finishing his PhD studies in Plant Molecular Biology and Biochemistry. He moved to the Centre for Novel Agricultural Products (CNAP), at the University of York, as a Postdoctoral researcher …

Marian Rehak - Director of Research and Development

Sphere Fluidics

Dr Rehak is responsible for the management of all Research and Development (R&D) and Manufacturing activities at Sphere Fluidics. He has a strong research background and more than 20 years’ experience in industrial and academic R&D environments. …

Marie Just Mikkelsen - Director of Technology

Estibio

Marie Just Mikkelsen joined Estibio ApS as Director of Technology in 2012. The Company’s proprietary best-in-class technology platform integrates a pentose/hexose co-fermentation process with its patented Pentocrobe® microorganisms providing rapid, efficient high yield bioethanol production. The platform is based …

Marie Lee - Vice President of Applications

Transcriptic

After receiving her B.S. in Genetics from the University of California in Davis, Dr. Marie M. Lee completed her Ph.D. in Cell and Molecular Biology from the Roswell Park Cancer Institute. Dr. Lee then continued to study …

Mark Bünger - Research Director

Lux Research

Mark Bünger is a Research Director at Lux Research, with over 20 years of business strategy experience as a management consultant and technology analyst. In this time, he has advised more than 40 Fortune 500 corporations, led …

Mark Lynas - Environmental writer

Mark Lynas

Mark Lynas is the author of three major popular science environmental books: High Tide (2004), Six Degrees (2008) and The God Species (2011), as well as the Kindle Single ebook Nuclear 2.0 (2012). Six Degrees won the …

Mark Segal - Senior Microbiologist

EPA

Mark is currently a Senior Microbiologist in the Risk Assessment Division (RAD). My major activities include providing science support for the TSCA Biotechnology Program. I am currently a member of the interagency Biotechnology Working Group which is …

Mark Wigglesworth - Director High Throughput Screening

AstraZeneca

Mark Wigglesworth holds a BSc. degree in Neuroscience from Nottingham University and gained his PhD at Leeds University by completing a project on forced evolution. Since then he has worked for both GlaxoSmithKline and AstraZeneca, focusing on …

Markus Gershater - Chief Scientific Officer

Synthace

Markus co-founded Synthace after working as a Research Associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering. Prior to UCL, he was a Biotransformation Scientist at Novacta Biosystems working as part …

Mary Ward - Co-Founder

Counter Culture Labs

Mary is a co-founder of Counter Culture Labs, an open community lab in Oakland. Counter Culture Labs seeks to accelerate scientific innovation and science literacy through open access. Building on this project, Mary is developing a network …

Matt Ocko - Managing Partner

Data Collective

Matt Ocko is co-Managing Partner and co-founder of Data Collective (DCVC), a venture capital firm that backs innovative entrepreneurs building deep compute, big data, and IT infrastructure companies able to transform huge markets, including life sciences, traditional …

Matthew Chang - Associate Professor

National University of Singapore

Matthew Chang is Associate Professor at the National University of Singapore. He has made contributions in synthetic biology, publishing over 50 peer-reviewed articles. His research interests lie in synthetic biology of microbial systems, with particular emphasis on development of synthetic microbes that perform programmable functions …

Max Hodak - Chief Executive Officer

Transcriptic

Max Hodak is the founder of Transcriptic. He holds a BSE in Biomedical Engineering from Duke University.

Meagan Lizarazo - Vice President of Operations

iGEM Foundation

Meagan Lizarazo is the Vice President of Operations of the iGEM Foundation. The iGEM Foundation is an independent nonprofit dedicated to education and competition, advancement of synthetic biology, and the development of open community and collaboration. It …

Megan Palmer - Deputy Director of Policy and Practices

SynBERC

Dr. Megan J. Palmer’s work seeks to develop, promote and advise on best practices and policies for responsibly advancing synthetic biology, and biotechnology more broadly. She is currently a William J. Perry Fellow in International Security at …

Michael Fero - Chief Executive Officer

TeselaGen

Michael Fero is a Co-Founder and CEO of TeselaGen Biotechnology Inc., which develops software systems for large scale production of DNA assemblies and combinatorial libraries. Michael received his Ph.D. in Physics from the University of California at …

Michael Flanagan - Founder and Chief Executive Officer

FlanaGen

Michael J. Flanagan, Ph.D., is Founder and Chief Executive Officer of FlanaGen LLC, based out of New York City.  Before starting FlanaGen last year, he was Chief Technology Officer at UK startup Arieso Ltd., which was acquired …

Michael Florea - Founder

SynBIC

Michael is a BSc Biology student at Imperial College, and an alumnus of Imperial iGEM. He is currently researching genetically engineered biomaterials in Ellis lab at Imperial. In 2014, he co-founded SynBIC with other Imperial students and …

Michael Koepke - Director of Synthetic Biology

LanzaTech

Michael is a pioneer in genetic engineering of gas fermenting organisms. His research on Clostridium ljungdahlii demonstrated for the first time that gas fermenting acetogens can be genetically modified and provided a genetic blueprint of such an …

Michael Krel - CEO

EnobraQ

Michael Krel is the CEO of EnobraQ. He is also senior associate within the IB practice of Sofinnova Partners, one of the leading VC in this space. Before that, he spent 6 years leading business development efforts for Metabolic …

Michael Molitor - Visiting Professor

Centre for Research and Interdisciplinarity (CRI)

Michael is a visiting professor in the International Energy Program at SciencesPo in Paris. He also serves as a Senior Advisor to the Climate Bonds Initiative – working to create a global standard by which climate bonds …

Michael Roberts - Chief Scientific Officer

Synpromics

Dr Michael Roberts read Biochemistry at the University of Glasgow, where he took a first class bachelor of sciences honors degree. He subsequently studied for his doctorate at the University of Cambridge where his interest in the …

Michael Yates - Business Development

Algenuity

Michael Yates serves in business development for Algenuity, and he is responsible for developing and implementing strategy to make Algenuity profitable. In the last year, he has worked closely with his Director, Andrew Spicer, to oversee product …

Michel Manach - Business Development

Toulouse White Biotechnology

Engineer in Biochemistry from INSA (Lyon-France), Michel Manach has worked internationally in Companies developing tools for the Biotechnologies. He occupied various position at management level in Pharmacia Biotech (now GE Healthcare), Sepracor, Applied Biosystems. He also created …

Mike Koeris - CEO

Sample6

Michael is a co-founder and CEO of Sample6 Technologies, a Synthetic Biology startup aiming to improve the health and safety of global consumers. Sample6 is developing integrated systems that can quickly and easily detect harmful and unwanted …

Mike Sheehan -

Mike Sheehan is CEO at Milis Bio. After a follow up question in a lecture snowballed considerably, Milis Bio was founded by Mike and the lecturer in question with the goal of making our relationship with sweeteners …

Monali Goswami -

Monali Goswami manages the Synthetic Biology design and support group at Integrated DNA Technologies which assists IDT’s clients and collaborators in designing, building and testing of synthetic constructs used in CRISPR, Car-T and many other immerging technologies. …

Morten Sommer - CEO

Biosyntia

Morten Sommer is Professor at DTU. Morten Sommer received his PhD from Harvard University in Biophysics. Before starting his own lab Morten Sommer worked with professors George Church, Stephen Quake and Sine Larsen. Morten Sommer now works …

Nan Li - Principal

Obvious Ventures

Nan Li brings a mixed technology, investing and entrepreneurial background to Obvious Ventures. Prior to joining OV, Nan managed early stage tech investments for Eric Schmidt’s Innovation Endeavors. He has been a venture investor/advisor for the past …

Natalia Verza - Operations Development Coordinator

Oxitec

Natalia Verza is a Biotechnology, Genetics and Molecular Biology PhD from State University of Campinas, Brazil. She is currently an Operations Development Coordinator at Oxitec Brasil, and has worked as R&D/Molecular and Synthetic Biology leader in the …

Nathan Hillson - Director of Synthetic Biology Informatics, Fuels Synthesis and Technologies Divisions

U.S. Department of Energy’s Joint BioEnergy Institute

Dr. Nathan J. Hillson is the Director of Synthetic Biology Informatics, Fuels Synthesis and Technologies Divisions, at the U.S. Department of Energy’s Joint BioEnergy Institute. Hillson is also the Group Lead of Synthetic Biology Informatics at the Department of Energy’s Joint …

Nathan Wood - President

SGI DNA

Mr. Nathan Wood has been President of SGI DNA, Instruments and Reagents since March of 2014. Prior to joining Synthetic Genomics he was General Manager at Thermo Fisher Scientific’s Synthetic Biology business unit. Thermo Fisher Scientific acquired …

Natsai Audrey Chieza - Founder & Creative Director

Faber Futures

Natsai is Founder and Creative Director of R&D studio Faber Futures. The design studio’s research and creative consultancy is driven by a desire to conceptualise, prototype and evaluate the resilience of emerging systems of manufacturing that are …

Neal Carter - President & Founder

Okanagan Specialty Fruits

Neal Carter is the president and founder of Okanagan Specialty Fruits Inc. (OSF), a dynamic agriculture biotechnology company specializing in the creation of novel tree fruit varieties. OSF’s flagship project, nonbrowning Arctic® apple varieties, recently became the …

Nethaji Gallage - Postdoc fellow

University of Copenhagen

I am a bioengineering-scientist at Centre for Synthetic Biology, University of Copenhagen (UCPH). My work is primarily focused on discovery, elucidation and bioengineering of plant high-value compounds with a view to contribute to an environmentally sustainable bio-production …

Nevin M. Summers - Executive Director

MIT Synthetic Biology Center

Nevin Summers is Executive Director of the MIT Synthetic Biology Center and a Research Scientist in the Ron Weiss Lab. He is responsible for technology development and management, including IP strategy, fund-raising and collaborative relationships with industry …

Nick Conley -

EpiBiome

Dr. Conley is Chief Executive Officer, Co-founder, and a Director of EpiBiome. He completed a PhD in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University, where he trained as a synthetic chemist and molecular …

Nicola Cahill - Field Application Specialist

Pacific Bioscience

Nicola Cahill Ph.D, Field Application Specialist, Pacific Biosciences, UK and Nordics

Nigel Fleming - Chairman and CEO

G2B Pharma

Serial entrepreneur, professional board member, pitch judge, speaker and panel chair. PhD Cambridge U, postdoctoral Boston U, Lecturer HARVARD Med School.

Nigel Saunders - Professor

Brunel University London

Nigel Saunders has medical and scientific backgrounds in bacteriology and genomics. He trained in infection at Imperial College / Hammersmith Hospital; in molecular biology and genomics in the Molecular Infectious Disease group in the Institute for Molecular …

Nimesh Pinnamaneni - CEO

Helixworks Technologies

Nimesh co-founded Helixworks to democratize access to cutting edge tools in biotech like the personal computer did for everyone.

Noga Qvit-Raz - Founder

TopgeniX

Scientist with 15 years of expertise in clinical and environmental microbiology, focusing on microbial ecology, environmental studies, microbial communities characterizations, single-cell genomics, microbiome, high throughput data analysis and molecular biology. Post-doc training at Stanford University, focusing on …

Núria Conde Pueyo - CSO

Moirai Biodesign

Núria is a biologist and engineer in computer science. She holds a doctoral thesis in biocomputing, which consists on genetically modify the cells to carry out any desired computing operation. It accumulates more than 7 years of …

Oliver Sexton - Investment Director

Rainbow Seed Fund

Oliver manages the Rainbow Seed Fund’s synthetic biology investments. Prior to joining Rainbow Oliver spent five years at Imperial Innovations where he was responsible for the early investment and commercialisation of bioengineering technologies. Earlier in his career …

Olivier Jarry - Global Life Sciences & Consumer Health Executive

Growth Markets Builder

Olivier leverages 30 years of passion improving health and living standards throughout Western / Eastern Europe, the Americas and Asia to create sustainable, profitable growth, organically and inorganically, in the Life Sciences, Consumer Health, Nutrition and Consulting …

Omri Amirav-Drory - Head of Corporate Development

Twist Bioscience

Omri Amirav-Drory, Ph.D. is the founder & CEO of Genome Compiler Corp, a Synthetic Biology venture. Prior to starting his company, Dr. Amirav-Drory was a Fulbright postdoctoral research fellow at Stanford University School of Medicine & HHMI, …

Orkan Telhan - Co-Founder

Biorealize

Orkan Telhan, Ph.D., is Assistant Professor of Fine Arts – Emerging Design Practices at University of Pennsylvania, School of Design. He holds a PhD in Design and Computation from Massachusetts Institute of Technology (MIT) with a focus on …

Orr Yarkoni - CEO

Colorifix

Orr is CEO and co-founder of Colorifix. For the last 10 years he’s been applying his skill-set bridging synthetic biology with nanotechnology to biosensors, including the Cambridge/Edinburgh Arsenic Biosensor Collaboration.Orr is passionate about creating a symbiotic relationship …

Patrick Westfall - Scientist

Zymergen

Before joining Zymergen in 2015, Patrick Westfall was the group leader for Molecular Biology and Analytics at Dow AgroSciences in the Advanced Technology Development department where he led efforts to deploy synthetic biology design principles to Dow’s …

Patrick Yizhi Cai - co-Director

Edinburgh Genome Foundry

“Patrick” Yizhi Cai received a bachelor degree in Computer Science in China, a master degree in Bioinformatics from University of Edinburgh in the UK, and a PhD in Genetics, Bioinformatics and Computational Biology from Virginia Tech in the USA. Cai …

Paul Feldstein - Chief Executive Officer

Circularis

Dr. Feldstein received his PhD in Biochemistry from UC Davis. He has extensive experience in nucleic acid biochemistry and has worked extensively on subviral pathogens of plants. He is cofounder of Circularis, a company in IndieBio’s second class, and …

Paul Freemont - Co-Director

SynbiCITE

Professor Paul Freemont is co-director and co-founder of the EPSRC Centre for Synthetic Biology and Innovation (since 2009) and the National UK Innovation and Knowledge Centre for Synthetic Biology (SynbiCITE; since 2013) at Imperial College London. He …

Paul Hill - Director of Process Development

Amyris

Paul is the Director of Process Development at Amyris. Over the past 5 years, he has led the successful development, scale-up and transfer of Amyris fermentation technology to multiple sites around the world.

Paul Lomax -

Paul Lomax is product manager for TTP Labtech, sample management products. With over 15 years experience in the automation of life science applications he is responsible for TTP Labtech’s range of novel automated -20oC and -80oC storage …

Paul Rothwell - Senior Research Scientist

Touchlight Genetics

Paul graduated from the University of York with a BSc in Biochemistry and an MRes in Biomolecular Science. He studied for his Doctorate at the Max-Planck Institute for Molecular Physiology working on the kinetic and biophysical characterization …

Paul Young - Chief Scientific Officer

MilisBio

Dr. Paul Young is Chief Scientific Officer of MilisBio and Principal Investigator at UCC (Ireland). Diverse exposure to cutting-edge neuroscience including research at EMBL Heidelberg (GER) as well as Duke University (US) contributed to his outstanding insights into SynBio applications. …

Per Tomani - Business Development Manager

LignoCity

Per is Business Development Manager at RISE Bioeconomy (previous company names: Innventia and the Swedish Pulp & Paper Research Institute). His main responsibility today is within the business unit Biorefining & Energy. Per has about 25 years …

Peter Ackermann - Industry Liaison Officer

Synberc

Peter Ackermann is Industry Liaison Officer at Synberc, a multi-institution synthetic biology research organization bringing together the field’s academic and industry leaders. Peter develops the center’s value proposition for diverse industries and attracts new member companies. He …

Peter Haslett - Head of Client Development

Realeyes

Peter has thoroughly enjoyed a career in consumer research spanning 20+ years – including board-level leadership at Ipsos in global, European and North American roles – working with a range of local and global clients in automotive, …

Peter Widdowson - CEO and Co-Founder

Quethera

Peter Widdowson is CEO and Co-Founder of Quethera. He has over 30 years of drug discovery project management experience from animal models to clinical proof-of-efficacy studies in large pharmaceutical (Servier, AZ, Pfizer) and biotechnology (OSIP, Oxford BioMedica) companies …

Petra Oyston - Technical Fellow Molecular Microbiology and Synthetic Biology Chemical, Biological and Radiological Division

DSTL

Petra Oyston is Dstl’s lead on Synthetic Biology, with a role in identifying potential applications for this emerging and potentially disruptive technology to address some of the intractable problems faced by defence. The focus of her efforts has …

Philippe Gabant - Chief Scientific Officer

Syngulon

Dr. Philippe Gabant, is one of the founders and the CSO of Syngulon SA. Philippe holds a PhD in Molecular Biology from the Université Libre de Bruxelles (ULB) and a Master in Management de l’Innovation from HEC …

Philippe Marlière - Co-founder

Global Bioenergies

Philippe Marlière is a scientist, inventor and entrepreneur. As a group leader in the Institut Pasteur from 1987 to 1999, he pioneered the development of synthetic biology approaches for reprogramming metabolism and evolving the genetic code of …

Piers Millett - Principal

Biosecure

Piers D Millett, Ph.D. is Principal of Biosecure Ltd, a company dedicated to safeguarding the bioeconomy. Dr. Millett currently consults for the World Health Organization supporting their R&D efforts. Piers also holds a Global Fellowship at the …

Ping Yang -

Synbio Technologies

Ph.D. Ping Yang, who had long been a top executive in the multinational Biotech Corp, is an experienced senior manager as well as a famous expert in the field of synthetic biology and pharmaceutical development. As a …

Poh Chueh Loo - Assistant Professor

Nanyang Technological University

Dr. Chueh Loo Poh is an Assistant Professor with the Division of Bioengineering at Nanyang Technological University (NTU), Singapore since 2007. He obtained his PhD in Bioengineering from Imperial College London and B.Eng. in Electrical and Electronic …

Rachel Haurwitz - Chief Executive Officer

Caribou Biosciences

Rachel Haurwitz is the CEO and co-founder of Caribou Biosciences as well as a co-founder of Intellia. She has a research background in CRISPR biology, and in 2014 she was named by Forbes to the “30 Under 30” …

Randal Kirk - Chairman of the Board & CEO

Intrexon

Randal J. Kirk serves as Chairman of the Board and Chief Executive Officer of Intrexon Corporation, a market leader in synthetic biology, which is addressing global challenges in health, energy and food through the application of biotechnology. …

Randy Dyer - Director of Product Marketing

Labcyte

Randy has spent over 15 years contributing to the launch and management of products for life science research. His team manages Labcyte’s instrument, software, and systems platforms and guides the development of new products from Labcyte.

Randy Rettberg - President & Founder

iGEM Foundation

Randy Rettberg is the President and Founder of the iGEM Foundation. The foundation’s primary programs are the International Genetically Engineered Machine competition (iGEM), which is the premier educational program in synthetic biology, and the iGEM Registry of …

Ravi Sachidanandam - CEO

Girihlet

Ravi Sachidanandam co-founded Girihlet Inc. to bring our genomic technologies to the market. They have developed several technologies, including unbiased small RNA sequencing, mtDNA purification and profiling and methods of TCR repertoire profiling. He is also on the faculty of the …

Reese Jones - Associate Founder

Singularity University

Reese Jones is an angel investor for synthetic biology start-ups and serves on numerous councils and boards in both biological and technological industries. He was also Founder of Netopia, a broadband internet service which was later acquired …

Rémi Bernard - Strain Construction Team Leader

DEINOVE

Rémi Bernard, Strain construction Team leader at Deinove, is PhD in Molecular Microbiology and Biotechnology. He was Research Associate at Harvard Medical School, Boston (USA), before joining Deinove. He is the author of two patent families covering …

Renee Wegrzyn - Program Manager in the Biological Technologies Office

DARPA

Dr. Renee Wegrzyn is a Program Manager in the Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA). She is interested in applying the tools of synthetic biology to support biosecurity and outpace infectious …

Reshma Shetty - Founder

Ginkgo BioWorks

Reshma Shetty co-founded synthetic biology Ginkgo BioWorks in 2008 and has helped to grow the company to 22 people and raised > $10M in non-dilutive capital. Reshma Shetty has a B.S. degree in Computer Science from the University …

Richard Hammond - Head of Synthetic Biology

Cambridge Consultants

Richard Hammond is responsible for building Cambridge Consultants’ business and technical capabilities in DNA-based technologies, particularly around the growing discipline of synthetic biology.

Richard Kitney - Co-Director

SynbiCITE

Professor Kitney is Chairman of the Institute of Systems and Synthetic Biology; and Co-Director of the EPSRC National Centre for Synthetic Biology and Innovation and The UK National Industrial Translation Centre for Synthetic Biology – both at …

Richard Yu - Scientific and Operations Director

QB3@953

Richard Yu is the Scientific and Operations Director of QB3@953, San Francisco’s premiere life science incubator in the heart of the Dogpatch. At QB3@953, his mission is to lower the barriers to success for life science startups, …

Riley Doyle - Chief Executive Officer

Desktop Genetics

Chief Executive Officer and Founder, Desktop Genetics Riley founded Desktop Genetics in August 2012 after graduating from with the University of Cambridge after completing his Master’s in Bioscience Enterprise degree. Prior to Cambridge, Riley worked as a bioprocess engineer at …

Rob Carlson - Managing Director

Bioeconomy Capital

Rob Carlson is a Managing Director of Bioeconomy Capital. He serves as a strategic and technical advisor to a range of start-up and established corporations and to governments around the world. Carlson is the author of Biology …

Rob Marchmont - Commercial Director

Sphere Fluidics

Dr. Marchmont brings to Sphere Fluidics more than 25 years’ experience in privately-owned and publicly-traded Life Sciences companies. He has a proven track record in business development, technical selling and strategic marketing. Previously, Rob has held various …

Robert Blazej - Manager

Novozymes

Robert Blazej manages Novozymes’ San Francisco Digital Biotechnology department. He was formerly co-founder and CEO of Allopartis Biotechnologies, a company founded to develop optimized biocatalysts for industrial enzymes and synthetic biology. Allopartis was acquired by Novozymes in …

Robert McIntyre - VP of Business Development

TeselaGen

Robert has spent over 15 years bringing start-up software technologies to market.  Prior to joining TeselaGen as the VP of Business Development, Robert served the same role at NextBio (acquired by Illumina), the leader in Big Data analytics for whole-human genome sequencing. …

Rocky Cranenburgh - Chief Scientific Officer

Prokarium

Rocky is the Chief Scientific Officer and co-founder of Prokarium Ltd, a UK-based biotechnology company specialising in the oral delivery of novel recombinant vaccines. Prokarium’s Vaxonella® platform uses attenuated Salmonella to express and deliver vaccines via the lining of …

Rodrigo Martinez - Life Sciences Chief Strategist

IDEO

Rodrigo Martinez is passionate about the crossroads of design + biology at all scales. As Life Sciences Chief Strategist and Senior Portfolio Director at IDEO he tackles some of the most interesting challenges in service design in …

Roger Chen - Associate

O’Reilly AlphaTech Ventures

Roger is an Associate at O’Reilly AlphaTech Ventures (OATV), where he looks for collisions between unmet needs and enabling technologies in underserved spaces. He spent his past life as a scientist and engineer, alternating between academia and …

Ron Leuty - Reporter

San Francisco Business Times

Ron Leuty has been a reporter or editor for more than 25 years, including editor of two startup business journals and business editor of the Prague Post in the Czech Republic. Ron has covered biotech for the …

Ron Shigeta - Chief Science Officer

IndieBio

Ron Shigeta PhD is a veteran of the biotechnology industry in the San Francisco bay area and has also participated in several startups during that time as employee, consultant and principal. In early 2014 he was a …

Ron Weiss - Professor of Biological Engineering

MIT

Prof. Weiss is one of the pioneers of synthetic biology.  He has been engaged in synthetic biology research since 1996 when he was a graduate student at MIT and where he helped set up a wet-lab in …

Rosalind Le Feuvre - Director of Operations

SYNBIOCHEM Centre for Synthetic Biology Research

Ros is Director of Operations for the SYNBIOCHEM Centre for Synthetic Biology Research at the Manchester Institute of Biotechnology (MIB), University of Manchester. Founded in 2014, the UK Research Council (BBSRC/EPSRC) funded Centre provides a suite of …

Roy Nevo - Chief Technology Officer

Genome Compiler

Roy Nevo is Co-Founder and CTO of Genome Compiler Corporation, a synthetic biology venture which is creating a CAD tool for engineering biological applications. Prior to starting his company, Roy was a senior software engineer at Intel leading …

Rt. Hon. David Willetts -

David Willetts was Minister for Universities and Science, attending Cabinet, from 2010-2014. He has been the Member of Parliament for Havant since 1992. He has worked at HM Treasury, the Number 10 Policy Unit, and served as …

Ryan Bethencourt - Program Director and Venture Partner

SOSventures

Ryan prides himself on disrupting the current status quo in both medical and consumer biotech. He was previously the Life Sciences head at the XPRIZE Foundation,  the co-founder and CEO of Berkeley Biolabs, as well as a co-founder of Sudo …

Ryan Burnette - Director, International Biosecurity & Biosafety Programs

AT-RISK International

Ryan Burnette is an international biosecurity and biosafety practitioner having worked extensively in both North America and overseas markets. He has consulted on biocontainment, biosafety and biosecurity programs and has built relationships with clients and stakeholders in …

Ryan Cawood - Chief Executive Officer

Oxford Genetics

Dr Cawood is a genetic engineer and virologist with a 1st class degree in Genetics and a doctorate from the University of Oxford. He is the founder and CEO of Oxford Genetics Ltd, a UK-based biotech company focused on …

Sabrina German - Senior Research Associate

Primordial Genetics

Sabrina German is Senior Research Associate at Primordial Genetics Inc. where she has developed the company’s core technology and has helped launch pharmaceutical and industrial biotech R&D projects. Prior to Primordial, Sabrina spent 4 years at the …

Sajith Wickramasekara - Chief Executive Officer

Benchling

Sajith Wickramasekara started doing scientific research at Duke University when he was 15. He won the Siemens Prize for his work on personalized therapeutics. He is currently on leave from the Massachusetts Institute of Technology, where he …

Sam Altman - President

Y Combinator

Sam Altman is the president of Y Combinator and was co-founder and CEO of Loopt, which was funded by Y Combinator in 2005 and acquired by banking company Green Dot in 2012. At Green Dot, Sam was …

Sandra Rey - Founder & CEO

Glowee

Sandra is a 26 passionate and dreamy entrepreneur, who, after her diploma in industrial design, completed her formation with a social entrepreneurship degree. During her professional experience, she has always been surrounded by innovation and prospective, leading …

Sarah Haywood - CEO

MedCity

Sarah Haywood became Chief Executive Officer of MedCity in December 2015, after fulfilling the role in an acting capacity and then as COO since MedCity’s launch in April 2014. Sarah is a graduate of the NHS Management …

Sarah Lau - Partner in the Life Sciences & Chemistry Group

Kilburn & Strode

Sarah Lau is a patent attorney and Partner in the Life Sciences & Chemistry group at Kilburn & Strode LLP.  Sarah handles all aspects of the patent procedure, from identifying inventions and advising on patentability and IP …

Sarah Munro - Team Leader

Stanford University

Dr. Sarah Munro is the California Team Leader of the National Institute of Standards and Technology (NIST) Genome-Scale Measurements Group and an Executive Committee member for the NIST-Stanford Joint Initiative for Metrology in Biology (JIMB). JIMB unites …

Sarah Rodriguez - Scientist

Joint Bioenergy Institute

Sarah Rodriguez received her PhD in Molecular and Cellular Biology from the University of California at Berkeley in 2013 with Jay Keasling while studying regulating mechanisms of central metabolism via metabolic profiling with direct application to yeast bio-fuel …

Saurabh Srivastava - Chief Executive Officer

20n

Saurabh leads the Act Synthesizer project at UC Berkeley. The Act Synthesizer is a DARPA funded initiative aimed at removing the guesswork and intuition out of microbial chemical factories (MCF) design. The tool allows you to exploratively …

Scott Nolan - Partner

Founders Fund

Scott Nolan is a Partner at Founders Fund, where he focuses on investments in technology-driven companies across sectors including energy, synthetic biology, aerospace, healthcare and advanced manufacturing. Prior to Founders Fund, Scott was an early employee at SpaceX. There, …

Sean O’Sullivan - Managing Partner

SOSV

Sean O’Sullivan is managing partner of SOSV, the world-leading “Accelerator VC”. With $300 million assets under management, SOSV backs more than 150 startups annually through its accelerators.  Recognized in 2017 as the world’s #1 most active global …

Sean Simpson - Co-founder and Chief Scientific Officer

LanzaTech

Dr. Simpson is a Co-founder and Chief Scientific Officer of LanzaTech, a global leader in gas fermentation that has grown from a team of 3 in 2005 to a global technology company with entities in the US, …

Sean Sutcliffe - Chief Executive

Green Biologics

Sean Sutcliffe has served as Chief Executive of Green Biologics since April 2008, contributing to the company extensive commercial and operational experience across the energy and renewables sector. Prior to joining Green Biologics he was from 2005 …

Sean Ward - Chief Technology Officer

Synthace

Before co-founding Synthace, Sean was a Research Associate in Bioinformatics at University College London, where he conducted research into protein folding, protein structure prediction, and gene coding. Prior to his work in bioinformatics, Sean was the Co-Founder …

Seth Bannon - Founding Partner

Fifty Years

Seth Bannon is a Founding Partner at Fifty Years, a seed fund that backs entrepreneurs solving the world’s biggest problems with technology. Seth has invested in a range of syn bio startups shaping the world for the better — from …

Shaila Kotadia - Education and Outreach Manager

Synberc

Shaila Kotadia is the Education and Outreach Manager at the Synthetic Biology Engineering Research Center (Synberc), where she directs numerous programs at the pre-college through postdoctoral levels. Her strong interest in promoting diversity within STEM fields is …

Simon Bayly - Partner

Epiphany Capital

Simon Bayly works with entrepreneurs and early stage science and technology companies to raise venture capital and grow their business. He has PhD in chemistry from the University of Bristol and spent his early career in biomedical …

Simon Trancart - CEO

Heurisko

Simon Trancart is Heurisko CEO. He earned diplomas from the Ecole Centrale Paris (France) and Escola Politécnica da Universidade de São Paulo (Brazil). Previously, Simon served successively as Deputy Technical Director in Brazil, Product Manager and Regional …

Soheila Vaezeslami - Sr. Field Application Scientist

TTP Labtech

Soheila Vaezeslami, PhD,  is a senior field application scientist at TTP Labtech covering the application areas of synthetic biology. Soheila spent three years as an automation field application scientist at Rigaku Americas Corp. (The Woodlands, TX) and …

Spencer Adler - Chief Executive Officer

Bioeconomy Management

Spencer Adler is the CEO of Bioeconomy Management LLC, which advises startups in this space on strategic decision making and investor relations. He is also a partner, with Rob Carlson, in Bioeconomy Capital, a well-funded investment group …

Stephan Herrera -

Evolva

Stephan Herrera is VP, Strategy & Public Affairs at Basel, Switzerland-based Evolva , which is developing health, wellness, and nutritional ingredients through next-generation yeast-based fermentation. The Company has additional operations in Denmark, India, and the US. Herrera …

Stephen Chambers - CEO

SynbiCITE

Stephen Chambers is the CEO of SynbiCITE and has a wealth of experience in life science based start-up companies. Having completed his PhD at the University of Warwick, Steve joined the then start-up Vertex Pharmaceuticals as a …

Stephen del Cardayre - Vice President, Life Sciences Research and Development

REG Life Sciences

Stephen del Cardayre is responsible for research and development at REG Life Sciences. Prior to joining REG Life Sciences, Steve spent seven and a half years at LS9, Inc. (acquired by REG in 2014) where he was …

Stephen Gray - Postdoctoral Research Associate

BioChanges

Stephen G. Gray Postdoctoral Research Associate, Prof. Roger D. Kamm’s MechanoBiology & BioSym Lab, SMART Centre, Massachusetts Institute of Technology (MIT) web.mit.edu/meche/mb  www.linkedin.com/in/biochanges BHF Centre of Research Exellence PhD Scholar, Prof. Peter D. Weinberg’s Lab, Department of Bioengineering, Imperial …

Stephen Laderman - Director of the Molecular Tools Laboratory

Agilent Technologies

Stephen Laderman is Director of the Molecular Tools Laboratory in Agilent Laboratories, where he has worked since its inception in 1999, managing R&D programs and personnel inventing, developing and testing leading-edge measurement solutions for research and diagnostics. …

Steve Bates - Chief Executive Officer

BIA

Steve joined the BIA as its Chief Executive Officer in July 2012. He has worked both in biotech and the highest levels of UK government for 15 years. He was Senior Director, External Affairs and Market Access …

Steve Blank - Lecturer

UC Berkeley

A retired eight-time serial entrepreneur-turned-educator and author, Steve Blank has changed how startups are built and how entrepreneurship is taught around the globe. He is author of the bestselling The Startup Owner’s Manual, and his earlier seminal …

Steve Evans -

Steve received B.A. and B.S. degrees in Chemistry and Microbiology, respectively, from the University of Mississippi in 1981 where he was an NSF Undergraduate Research awardee in natural products analytical chemistry. He completed a Ph.D. in Microbial …

Steve Jurvetson - Managing Director

Draper Fisher Jurvetson

Steve Jurvetson is a Managing Director of Draper Fisher Jurvetson, where his current board responsibilities include SpaceX, Synthetic Genomics, and Tesla Motors (TSLA). He was the founding VC investor in Hotmail (MSFT), Interwoven (IWOV), Kana (KANA), and NeoPhotonics …

Steve Martin - Chief Executive Officer

BioSyntha

Steve has a background in technical and commercial development of bioprocesses in the Pharmaceutical and Industrial Biotechnology sectors. He has a successful track record of building and directing cross-disciplinary teams to develop innovative products and processes and …

Steve Somers - Chief Executive Officer

Vigon International

Steve Somers is President and Chief Executive of Vigon International, one of the Flavor and Fragrance industry’s fastest growing and most innovative companies based on its unique partnership based business model.  This model has driven Vigon’s growth …

Steven Moss - Chief Technology Officer

Isomerase

Steven is highly practiced at applying the chemical biology of microbial natural products to drug discovery. In particular, Steven is experienced in applying Isomerase’s bioengineering platform and semi-synthesis to generate microbial natural products with characteristics more suited to use …

Stewart Brand -

Stewart Brand is co-founder and president of The Long Now Foundation and co-founder of Global Business Network. He created and edited the Whole Earth Catalog (National Book Award), and co-founded the Hackers Conference and The WELL. His books include The Clock of the Long Now; How Buildings Learn; and The …

Susan Rosser - Director

UK Centre for Mammalian Synthetic Biology

Professor Susan Rosser holds a Chair in Synthetic Biology at the University of Edinburgh and is Director of the UK Centre for Mammalian Synthetic Biology (a BBSRC, EPSRC and MRC funded Synthetic Biology Research Centre) and Co-Director …

Suzanne Lee -

Modern Meadow

Suzanne brings 20 years of experience in design research and fashion including being an early pioneer and proponent of biotechnology in textiles. She started growing microbial materials in 2003 and went on to establish Biocouture, the first …

Tahel Altman - CEO

SynVaccine

Dr. Tahel Altman graduated from the Stanford Biodesign Innovation Fellowship, a leadership program in needs driven medical device innovation. She has earned a BSc degree in Life-science and a MD both from Tel Aviv University, and completed …

Tarig Dafaalla - Senior Scientist

Oxitec

Tarig Dafaalla is senior scientist at Oxitec Ltd. His role is to design and construct genetic modules to be incorporated in genomes of different insects and then can be applied as tools for their control. Before joining Oxitec, Tarig …

Taylor Milsal - Founding Partner

Now Labs

Taylor Milsal is a Founding Partner at San Francisco based innovation practice, Now Labs (formerly Milsal McCaull). For leading companies including Autodesk, Estee Lauder and Panasonic, we map new markets, scout for strategic partnerships and acquisitions, provide …

Ted Fjällman - CEO

Prokarium

Ted Fjällman is CEO of Prokarium, a UK biopharma company developing SynBio based vaccines against Chlamydia, C. difficile, diarrhoea and typhoid. Ted has previously worked for Sweden’s leading think tank where he coordinated the writing of a …

Teng Li - President

BluePHA

As the president, Dr. Teng LI is responsible for the research & development processes and operation of BluePHA. With expertise in Metabolic Engineering, Biochemical Processes and Biopolymer Sciences, he is leading the whole research team towards making …

Tessa Callaghan - Co-founder

AlgiKnit

With a background in knitwear, Tessa is focused on biodegradable materials and sustainable design. As a co-founder of AlgiKnit, she aims to incorporate algae based products into everyday life. She applies her knowledge and passion for knitwear …

Thomas Hitchcock -

Thomas Hitchcock, Ph.D. is the Founder and CEO of Xycrobe Therapeutics, Inc. Thomas  holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair. He has completed postdoctoral training …

Thomas Landrain - PILI

CEO

Thomas is the co-founder and president of the nonprofit organization “La Paillasse” in Paris, one of the world’s largest community laboratories, commonly called hackerspaces, that foster open access and open source biotechnologies. He is an active member …

Thomas Livelli -

Tom Livelli is the Vice President of Life Sciences at Promega Corporation, bringing with him over 30 years of experience in Molecular Cell Biology. Tom is responsible for the Pharma/Biotech and the Academic/Government market segments at Promega, …

Thomas P. Bostick - Senior Vice President, Environment Sector

Intrexon

Lieutenant General (Ret) Thomas P. Bostick is a 1978 graduate of the U.S. Military Academy and holds Master of Science Degrees in both Civil Engineering and Mechanical Engineering from Stanford University, and a PhD in Systems Engineering …

Thomas Ybert - CEO

DNA Script

Thomas YBERT is the CEO and co-founder of DNA Script. He holds an engineering degree and a PhD from Ecole Polytechnique. Thomas spent 3 years in the biotechnology department at Sanofi R&D from 2007 to 2010, where …

Tiangang Liu - Professor

Wuhan University

Professor Tiangang Liu started work in Wuhan University in 2010 and was recruited as “Chutian Scholar” professor in 2012. He has receieved many awards such as New Century Excellent Talents of Ministry of Education and National Natural …

Tim Dafforn - Professor

University of Birmingham

Tim Dafforn is a Professor at the University of Birmingham and founder of Linear Diagnostics Ltd. He has established himself as an expert in biophysical spectroscopy with a keen interest in synthetic biology. Professor Dafforn has developed …

Tim Fell - Chief Executive Officer

Synthace

Tim is an experienced technology venture entrepreneur with an R&D background in both the physical and life sciences. Before joining Synthace he spent 7 years as Chief Operating Officer of CellCentric, a leading epigenetics drug discovery company. …

Tim Gallagher - Chief Executive Officer

Genabler

Tim is a veteran bio-entrepreneur, having been a key figure at Upstate Biotechnology and Xcovery, Inc. He founded Upstate’s kinase expression and screening subsidiary in Dundee, Scotland (now a part of Merck KgA), and served as General …

Tim Gardner - Chief Executive Officer

Riffyn

Tim Gardner is the Founder and the CEO of Riffyn. He was previously Vice President of Research & Development at Amyris, where he led the engineering of yeast strain and processes technology for large-scale (1.2 million liter) …

Tim O’Reilly - Founder & CEO

O'Reilly Media

Tim O’Reilly is the founder and CEO of O’Reilly Media, and a partner at early stage venture firm O’Reilly AlphaTech Ventures (OATV). He is also on the boards of Maker Media (which was spun out from O’Reilly …

Toby Richardson - Vice President of Informatics

Synthetic Genomics

Dr. Toby Richardson has more than 20 years of experience in the fields of bioinformatics, enzymology, and molecular biology. Prior to joining SGI Toby spent ten years at Diversa Corporation, where he established and managed the company’s …

Todd Kuiken - Senior Program Associate

Woodrow Wilson Center

Dr. Todd Kuiken is a Senior Program Associate with the Science and Technology Innovation Program at the Woodrow Wilson Center where he explores the scientific and technological frontier, stimulating discovery and bringing new tools to bear on …

Tom Ellis - Assistant Professor

Imperial College London

Tom Ellis is a lecturer (Assistant Professor) in the Department of Bioengineering at Imperial College London and leads the Ellis Lab at the Centre for Synthetic Biology and Innovation (CSynBI). His research focuses on developing the tools …

Tom Knight - Co-Founder

Ginkgo Bioworks

Tom Knight spent most of his career in computer science and electrical engineering  at MIT, before playing a major role in creating the field of synthetic biology. In 1996 he seeded interest in the field at DARPA, and …

Tommy Duncan - Group Business Development Officer

Touchlight Genetics

Dr. Tommy Duncan holds the position of Group Business Development Officer at Touchlight Genetics, a biotechnology company with a DNA synthesis platform with broad utility across both therapeutic and non-therapeutic applications. Prior to joining Touchlight, Dr. Duncan …

Tonya Jackson - Global Product Manager

Sigma Aldrich

After completing her Master’s degree in cellular & molecular biology at SUNY at Buffalo, Tonya spent nearly 6 years in cell culture technical support with Life Technologies. There, she developed a strong love for the customer, interest …

Tracy Lessor -

Feinstein Kean Healthcare

Tracy has nearly 18 years experience in science and healthcare communications. At Feinstein Kean Healthcare, she partners with leading experts within industry, academia, non-profit and government organizations to help shape their communications strategies. With core expertise in …

Travis Bayer - Co-Founder and Chief Technology Officer

Asilomar Bio, Inc.

Travis Bayer is Co-Founder and Chief Technology Officer at Asilomar Bio, Inc., a company developing chemistry and genetics for improving crop yield and water efficiency in field crops. He is a biochemist with experience developing technologies for …

Un Kwon-Casado -

Caribou Biosciences

Un serves as Chief Strategy Officer for Caribou Biosciences. Prior to joining Caribou, she was VP of Corporate Development at Fluidigm Corporation where she led the strategic planning, business development and investor relations functions. Un began her …

Una Ryan - Chair

Bay Area BioEconomy Initiative

Una Ryan is Chair of The Bay Area BioEconomy Initiative a non-profit organization dedicated to fostering an atmosphere of innovation and collaboration in the San Francisco Bay Area. Dr. Ryan is Managing Director Golden Seeds (Silicon Valley), …

Véronique de Bruijn - Investment Director

Icos Capital

Véronique joined Icos Capital in 2011 bringing over 10 years practice in board room consulting and M&A expertise across Europe. Working at PwC she advised on multiple M&A transactions, from building the business case through closing the …

Victor Zhirnov - Chief Scientist

Semiconductor Research Corporation

Victor Zhirnov is Chief Scientist at the Semiconductor Research Corporation. His research interests include nanoelectronics devices and systems, properties of materials at the nanoscale, bio-inspired electronic systems etc. He has authored and co-authored over 100 technical papers …

Vijay Pande - General Partner

Andreessen Horowitz

Vijay Pande is a general partner at Andreessen Horowitz where he leads the firm’s investments in companies at the cross section of biology and computer science including areas such as digital therapeutics, cloud biology, and computational medicine. …

Vincent Mauro -

Dr. Mauro is a thought leader in the study of the regulation of gene expression at the level of protein synthesis, focusing on elements that affect translation initiation. His research has been developed at Promosome, with applications in bioproduction, …

Vincent Sewalt - Senior Director

DuPont

Dr. Vince Sewalt is Senior Director of Product Stewardship & Regulatory for DuPont Industrial Biosciences in Palo Alto, CA. Vince has ample experience in plant- and microbial biotechnology innovation and management of regulatory, safety, quality, and stewardship …

Volker Morath -

Volker Morath is a researcher in the field of Synthetic Biology and Protein Design, currently finalizing his PhD thesis at the Technical University of Munich (TUM) in the lab of Prof. Dr. Arne Skerra. Besides his research …

Vonnie Estes - Consultant

Consultant

Vonnie Estes is an accomplished executive with 25 years of bio-technology industry leadership and global experience in business development, project management, marketing, sales, fund raising, and mergers and acquisitions in, agribusiness and industrial biotech. During her career, …

Will Canine - Co-Founder

OpenTrons

Will Canine is the Co-Founder of OpenTrons, a member of Genspace NYC, part of The New Inquiry and an avid runner. He spent the first part of his career running political campaigns, but soon found technology was …

Wu Xiaoyun - Product Specialist

Analyitik Jena

Wu Xiaoyun, from Analyitik Jena AG China office, is a Product Specialist for Molecular Biology Solution of Life Science. She graduated from Microbiology Department of Nankai University and got Master degree of Genetics from Zhejiang University.

Xavier Duportet - CEO

Eligo Bioscience

PhD in synbio at MIT/INRIA Elected French Innovator of the Year in 2015 by MIT Tech Review Elected 30 under 30 in Europe by Europe1 Elected as one of the 100 changing the world by Challenges Cofounder …

Xin Li - Group Leader of Chemistry

Sphere Fluidics

Dr Xin Li is the Group Leader of the Chemistry Group in Sphere Fluidics Limited with over 18 years of experience gained from working for both academic, e.g. University of Cambridge, and industrial institutions, e.g. GlaxoSmithKline (USA and UK), Akubio …

Xin Liu - Principal Scientist

Sphere Fluidics

Xin Wu -

GENEWIZ

Ye Yin - CEO

BGI

Ye Yin, is committed to promoting the application of advanced biomedical and genomic technologies in clinical practice in order to reduce birth defect rates and curb the incidence of major diseases, with the overall goal of improving …

Yi Wu - Graduate Student

Tianjin University

Yi Wu is a PhD student at Tianjin University, under the supervision of Dr.Yingjin Yuan in the Key Laboratory of Systems Bioengineering, MOE. He is leading the effort to synthesize yeast chromosome X in the international Sc2.0 …

Yih-En Andrew Ban - Computational Platform Lead

Arzeda

Yih-En Andrew Ban is currently the Computational Platform Lead at Arzeda, responsible for all technical aspects of the computational enzyme and protein design platform. Having worked at the interface between computer science and biology for the past …

Yin Li - Professor

Tianjin University

Ying-Jin Yuan - Professor

Tianjin University

Ying-Jin Yuan received Ph. D. in Biochemical Engineering from Tianjin University in 1991 and was promoted as professor in 1995 at Tianjin University. Dr. Yuan was Awardee of NSFC Outstanding Scholar Funds in 2004. He was awarded …

Yogev Debbi - Chief Operating Officer

Genome Compiler

Yogev Debbi is the co-founder and COO of Genome Compiler.

Yong Li - Research Director

BGI

Yong li was born in 1981, and grew up in Wugang Hunan province. He earned master degrees in biology from Hua zhong Agriculture University, and has worked as an assisted researcher on biotechnology since 2007. And now, …

Yvonne Linney - Chief Operating Officer

Transcriptic

Dr. Linney has more than 25 years’ experience as an executive at industry-leading companies in the life sciences and diagnostics industries, joining Transcriptic in 2015 as Chief Operating Officer. Previously, from 2006-2014, Dr. Linney was an executive …

Zach Serber - Founder

Zymergen

Zach Serber is a founder at Zymergen. He was previously the Director of Biology at Amyris and the Principal Investigator on a DARPA contract to develop advanced tools for synthetic biology. Dr. Serber has 15 peer-reviewed publications, …

Zachary Apte - Chief Technology Officer

uBiome

Founded synthetic biology company based on microfluidics invention, funded by DOE. Inventor of statistical measure of intracellular organization. PhD, Biophysics, University of California, San Francisco.

Zavain Dar - Senior Associate

Lux Capital

Zavain is a Senior Associate at Lux working alongside and collaborating with passionate entrepreneurs building paradigm-shifting technologies to disrupt and engage large markets. Previously, an investor at Eric Schmidt’s Innovation Endeavors, he invested and worked with numerous …

Zhen Xie - Principle Investigator in Bioinformatics Division

Tsinghua University

Zhen Xie is a Principle Investigator in Bioinformatics Division, Tsinghua National Lab for Information Science and Technology at Tsinghua University. He holds his PH.D in Biology from University of Nevada Las Vegas. Before joining Tsinghua University, he did his postdoctoral training …